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INTRODUCTION 
A commonly held belief in biochemistry is that a knowledge of struc­
ture will lead to a better understanding of function. This has held true 
for many systems. When Perutz (1952) solved the three-dimensional struc­
ture of hemoglobin it paved the way for numerous advances in understanding 
the functions of this molecule. The mechanisms of many enzymes have been 
understood, at least in part, through determining the arrangement of amino 
acids in their active sites. The crystal structure of yeast tRNA^^^ has 
been known for more than ten years (Kim et al., 1974), and the primary 
sequences of over 200 tRNAs are currently known (Gauss and Sprinzl, 1985). 
This structural knowledge has provided a firm foundation for further 
study; however, we are still far from understanding the relationship of 
structure to the functions and specificity of transfer RNAs. 
In this study, nuclear magnetic resonance was used to investigate 
the solution structure and dynamics of transfer RNA substituted with the 
uracil analog 5-fluorouracil. Effects of solutions conditions on the 
NMR spectra were studied, and a detailed investigation of codon-anticodon 
interaction was made. The eventual goal of these studies is to relate the 
structural conformation of tRNA to the important biological functions of 
this molecule in the transmission of genetic information during protein 
synthesis. 
Function of tRNA 
Protein synthesis 
Transfer RNA is central to protein synthesis in all living systems. 
It recognizes a codon triplet of the messenger RNA and provides the amino 
acid specified by the codon to the growing polypeptide chain. In this 
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way, transfer RNA acts as the adaptor molecule in the flow of genetic 
information first hypothesized by Francis Crick (quoted in Hoagland, 1960) 
several years before the discovery of tRNA. A brief description of the 
role of tRNA in bacterial protein synthesis follows, for a more detailed 
review of this subject see Pongs (1978). 
Aminoacylation To function in protein synthesis, tRNA must first 
be aminoacylated. Twenty different aminoacyl-tRNA-synthetases, corre­
sponding to the 20 different amino acids in biological systems, esterify 
the carboxyl group of an amino acid to the 2' or 3' hydroxyl group of the 
terminal adenosine of its cognate tRNA(s) in an ATP requiring reaction. 
Frequently several tRNAs, termed isoacceptors, exist for a given amino 
acid. 
The essential feature of this system is a high degree of specificity. 
Because these enzymes must differentiate one species of tRNA from another 
with high fidelity, all tRNAs must have elements of uniqueness. Despite 
many years of investigation, the structural features of tRNA involved in 
"determining the specificity of aminoacylation are not known precisely. 
Rich and Schimmel (1977) have proposed a model in which synthetases inter­
act with tRNAs along the inside of the two branches of the L-shaped tRNA 
molecule, and contacts with the anticodon arm are important. However, 
recent studies have indicated that this generalization may not hold true 
for all tRNAs (Romby et al., 1985). 
Initiation Protein synthesis begins with N-formylmethionyl 
tRNA^®^ binding to the initiation codon of the mRNA (AUG or GUG) on the 
small (30S) ribosomal subunit. This process requires GTP and three initi­
ation factors, IF-1, IF-2, and IF-3. The resulting 30S initiation complex 
then reacts with the 50S ribosomal subunit, GTP is hydrolyzed, and the 
initiation factors are released to yield a 70S initiation complex with 
fMet-tRNAf®^ bound at the P-site on the ribosome. 
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Elongation Elongation of the polypeptide chain occurs by codon-
dependent binding of aminoacyl tRNAs to the A-site of the ribosome as a 
ternary complex with the elongation factor, EF-Tu, and GTP. A peptide 
bond is formed between the amino group of the aminoacyl-tRNA in the A-site 
and the carboxyl group of the fMet or nascent peptide in the P-site, 
through the catalytic activity of the peptidyl transferase center in the 
50S ribosomal subunit. The energy for peptide-bond formation comes from 
hydrolysis of the "energy rich" acyl-ester bond of the aminoacyl-tRNA at 
the P-site, which in turn is derived from ATP hydrolyzed during aminoacyl-
ation. The free tRNA at the P-site is released and the peptidyl-tRNA is 
then translocated from the A-site to the P-site. After translocation, one 
cycle of elongation has been completed. The vacant A-site now contains a 
new mRNA codon, to which a corresponding aminoacyl-tRNA can bind and start 
another round of elongation. 
Termination The elongation process continues until one of the 
three termination codons, UAA, UGA, or UA6, appears in the A-site. At 
this point, under the influence of three specific proteins called releas­
ing factors (RF-1, RF-2, RF-3), the ester linkage of the peptidyl-tRNA is 
hydrolyzed, releasing the completed polypeptide. The deacylated tRNA and 
mRNA are then expelled from the ribosome. 
During protein synthesis, tRNA is involved in several functions and 
interacts with numerous proteins and nucleic acids. Some of these inter­
actions require exquisite specificity, such as with aminoacyl-tRNA-synthe-
tases. Others, such as the formation of a ternary complex with EF-Tu and 
GTP, involve a group of tRNAs, and all tRNAs must be sufficiently alike 
to function in the same ribosomal apparatus during protein synthesis. 
Therefore, tRNAs must have elements of uniqueness and yet maintain a 
certain degree of similarity. The mechanism by which an enzyme or protein 
recognizes a specific tRNA or a group of tRNAs is not yet clear. 
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Other roles of tRNA 
Transfer RNA is involved in many biological functions other than 
protein synthesis. Aminoacyl-tRNAs are involved in regulating several 
bacterial amino acid biosynthetic opérons through attenuation (Yanofsky, 
1981). The tryptophan (trp) operon of E, ooli is the best characterized 
of these systems. Expression of this operon is sensitive to the relative 
levels of charged and uncharged tRNA^^P (Bertrand et al., 1975). The 
mechanism of regulation involves coupling transcription with translation 
of a short peptide coding region in the leader transcript while RNA poly­
merase pauses transcription at a specific site (Yanofsky et al., 1983). 
The leader peptide coding region contains two tandem trp codons. Ribosome 
stalling at either of these codons, caused by a deficiency of trp-tRNA^'^P, 
promotes formation of a transcript secondary structure which prevents 
transcription termination and the operon is expressed. However, if suffi­
cient trp-tRNA^^P is present to allow translation of the entire leader 
region, an alternative secondary structure is formed which causes termina­
tion of transcription (attenuation). 
Transfer RNAs also function as primers for DNA synthesis by reverse 
transcriptase of RNA tumor viruses (Dahlberg, 1980). Tryptophan tRNA is 
the primer for avian virus reverse transcriptase (Waters et al., 1975) 
whereas tRNA^^^ functions with the murine enzyme (Dahlberg, 1980). Other 
tRNAs may also be used by other viruses (Peters and Dahlberg, 1979). 
In enteric bacteria, tRNA, in conjunction with other components of 
the protein synthetic apparatus plays, a major role in metabolic regula­
tion through the stringent response to shut off RNA synthesis when protein 
synthesis is stopped (Cashel and Gallert, 1974). This regulation occurs, 
for example, when cells are subjected to amino acid starvation. When mRNA 
and deacylated tRNA are bound to the ribosome, the magic spot compounds 
pppGpp and ppGpp are synthesized and the cells adjust their metabolism by 
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ceasing rlbosomal RNA synthesis (Cashel, 1969). 
Several special tRNAs also transfer amino acids In non-rlbosomal 
dependent reactions, such as the tRNA^^-^ required for staph, epidemndua 
cell wall biosynthesis (Roberts, 1972). More detailed Information on the 
diverse roles of transfer RNA In cellular functions has been presented In 
a review by Larossa and Soil (1978). 
General Structural Features of tRNA 
Primary structure 
Transfer RNAs are polynucleotide chains, typically 75-90 nucleotides 
In length with an average molecular weight of 26,000. The first sequence 
of a tRNA molecule, yeast alanine tRNA, was announced In 1965 by R. Hoi ley 
and seven co-workers (Holley et al., 1965). They noted that the polynu­
cleotide chain could be arranged Into a cloverleaf secondary structure to 
optimize the Intrastrand Watson-Crick base-pairing. Presently, over 200 
tRNAs have been sequenced (Gauss and Sprlnzl, 1985), and all cytoplasmic 
tRNAs can be arranged Into this general cloverleaf pattern depicted In 
Figure lA. 
A generalized structure of tRNA (Fig. lA) consists of the amino acid 
acceptor stem, and three arms: the D arm, T arm, and antlcodon arm, each 
composed of a stem and loop structure. The acceptor stem contains the 5' 
and 3' ends of the tRNA, and terminates at the 3' end in the conserved 
sequence CpCpA. During aminoacylation, the cognate amino acid is ester-
ified to the ribose of the 3'-terminal adenosine. The D and T arm are so 
named because their loops invariably contain the modified nucleosides 
dihydrouridine (D) and ribothymidine (T). The antlcodon arm contains the 
three antlcodon nucleotides that play a direct role in the transfer of 
genetic information through Interaction with codon-triplets in the 
messenger RNA. 
Figure 1. Structural features of transfer RNA. 
(A) Generalized cToverleaf structure of tRNA. Invariant 
and semi-invariant residues are designated by capital 
letters. R is purine, Y is pyrimidine, and H is hypermodi-
fied purine. Major land marks on the structure are 
indicated. 
(B) Two views of a schematic diagram of the tertiary struc­
ture of yeast tRNA^^^. The sugar-phosphate backbone of the 
molecule is represented as a tube with cross-rungs showing 
the nucleotide base-pairs. Dark circles represent four 
magnesium hydrate ions and "spaghetti" represents spermine 
molecules 
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As a rule, the number of nucleotides in stems and loops of tRNA is 
constant. The acceptor stem contains seven nucleotide-pairs, the T and 
anticodon stems each contain five base-pairs each, and three or four base-
pairs are found in the D stem. Seven nucleotides are usually found in the 
T and anticodon loops. Two variable regions, alpha and beta, occur in the 
D loop (Fig. lA), each containing one to three nucleosides in addition to 
the five constant purine residues found in this loop. The largest site of 
size variability among tRNAs is the variable (V) loop, which consists of 
four or five nucleosides in most tRNAs (class I) but can contain up to 21 
nucleosides (class II). 
A number of positions in the cloverleaf sequence are occupied by 
constant (invariant) nucleotides, as indicated in Figure lA. Other posi­
tions are semi-invariant, occupied exclusively by purines (R), pyrimidines 
(Y), or hypermodified nucleosides (H). Most of the invariant and semi-
invariant nucleotides are found in the loop regions of the molecule (Fig. 
lA). The general features and implications of the primary and secondary 
structure of tRNA are discussed in a review by Clark (1978). 
Several tRNAs, usually those having special functions, deviate 
slightly from the cloverleaf shown in Figure. lA (Clark, 1978). Only 
mitochondrial tRNAs are known to show large deviations from this general 
structure (Roe et al., 1981). Sequence data from bovine mitochondrial 
tRNAs demonstrate that, with the exception of tRNA^®", all of the 22 spe­
cies lack features coiranonly found in other tRNAs. The extreme case is 
tRNA^®*", which lacks the entire D arm (DeBruijn et al., 1980). 
Modified nucleosides 
An interesting aspect of the primary structure of tRNA is the pres­
ence of nucleosides other than the four normally found in RNA. More than 
50 different modified nucleosides have been isolated and characterized 
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(McClosky and Nishimura, 1977). These modifications range from simple 
methylation of the base, or Z'-O of ribose, to complex hypermodified 
nucleosides. The extensive degree of nucleotide modification in tRNA is 
one of the unique features of these molecules. 
Most of these nucleosides result from post transcriptional enzymatic 
modification of a major nucleotide in the tRNA molecule. However, at 
least one modification, guanine to queosine (Q), takes place at the nucle­
oside level (Agris and Soil, 1977). One enzyme generally modifies a given 
residue at a specific site in all tRNAs; m^U-methylase, for example, cata­
lyzes the synthesis of ribothymidine in the T loop of all E. aoli tRNAs 
(Greenberg and Dudock, 1980). However, the same modification at different 
sites in a tRNA may involve several enzymes, as is the case in pseudouri-
dine synthesis (Green et al., 1982). 
Modified nucleosides are usually located at specific positions in the 
cloverleaf structure of tRNA; starred nucleotides in Figure lA are ones 
that are usually modified. For example, ribothymidine (T) and pseudouri-
dine (v) are almost always found at positions 54 and 55. Hypermodified 
nucleosides are often found in the first position of the anticodon, or 3'-
adjacent to it. 
Their complex structures, specificity of location in the molecule, 
and presence in tRNA from all organisms suggests that modified nucleosides 
play an important role in the function of tRNA. Several functions pro­
posed for modified bases include affects on the stability (Nishimura, 
1977) and specificity (Yokoyama et al., 1985) of codon-anticodon interac­
tion, and protecting tRNA from attack by ribonuclease (Roe et al., 1973). 
Modified bases may also be involved in protein recognition of tRNA (Kim, 
1978). However, despite intensive research in this area, there is pres­
ently no real proof of an important universal role of modified nucleosides 
in tRNA function. Indeed, several studies have shown that some tRNAs 
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remain fully functional without certain modifications (Ramabhadran et al., 
1976; Horowitz et al., 1974). 
Three dimensional structure of yeast tRNA^^^ 
Overall structure A schematic illustration of the three-dimen-
sional structure of yeast tRNA''^®, as determined by X-ray crystallography, 
is shown in Figure IB (Kim et al., 1974; Sussman et al., 1978). The mole­
cule is L-shaped, with the anticodon loop at one end of the L, and the 
amino acid acceptor stem at the other end. Each extension of the L is 
about 60 A long and about 20 A in diameter. The hydrogen bonding pattern 
in the cloverleaf (Fig. lA) is maintained in the three-dimensional struc­
ture. When the polynucleotide backbone folds the amino acid stem and the 
T stem form one continuous double helical arm, and the D stem and the 
anticodon stem form the other long double helical arm of the L. 
The T and D loops meet at the corner of the molecule, and tertiary 
interactions between these loops stabilize the molecular conformation. 
Several of these tertiary interactions involve invariant or semi-invariant 
residues (Figure IB and lA), and most involve non-Watson-Crick type inter­
actions such as the reversed Hoogsteen base-pair m^A58-T54, and the base-
triplet G22-C13-m^G46. Base stacking is the major stabilizing feature of 
the molecule (Quigley and Rich, 1976) and involves all but 5 of the 76 
nucleotides in tRNA^^^; the unstacked bases are located in the variable 
regions of the D loop, in the variable loop, and in the 3' terminus. 
The anticodon loop The conformation of the anticodon loop is 
similar to that suggested by Fuller and Hodgson (1967). Five bases, 
including the anticodon triplet, are stacked on the 3' side of the loop 
(Fig. IB). A sharp U-turn separates these bases from the invariant 
uridine-33 located 5' to the anticodon. This conformation is stabilized 
by several factors including a hydrogen bond from N3 of U-33 to the 
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oxygen of phosphate-36 and a magnesium 1on coordinated to a phosphate 
oxygen of residue 37. The significant feature of the anticodon is that 
the bases are stacked in a right-handed helical array which points outward 
from the loop (Fig. IB), and presumably is ready to interact with the 
codon. 
Magnesium and spermine The importance of metal ions and cationic 
polyamines in stabilizing the three-dimensional structure of tRNA has long 
been recognized (reviewed by Teeter et al., 1980). Four distinct magne­
sium ions have been identified in the crystal structure of yeast tRNA^^^ 
(Fig. IB) (Quigley et al., 1978). All are found in nonhelical regions and 
serve to stabilize the loops and turns of the tRNA structure. Two of 
these ions are located in the D loop, one in the anticodon loop, and one 
in the sharp turn formed by residues 8 through 12. 
Two spermine molecules are found bound to tRNA^^^ (Fig. IB). One, 
located in the major groove at the end of the anticodon stem draws the two 
opposite ribose phosphate backbones closer together and stabilizes a 25° 
kink between the anticodon stem and the D stem (Quigley et al., 1978). 
The second spermine is found near the variable loop and stabilizes a sharp 
turn in the polynucleotide chain. 
Structure of other tRNAs The finding that most of the tertiary 
interactions in tRNA^^^ Involve conserved or semi-conserved bases suggests 
that all tRNAs have the same general structural frame (Klug et al., 1974). 
The crystal structures of four other transfer RNA molecules have been 
investigated: E, ooli tRNA^^ (Woo et al., 1980), yeast tRNA^^^ (Wright et 
al., 1979), yeast initiator methionine tRNA (Sussman and Podjarny, 1983), 
and aspartic acid tRNA from yeast (Westhof et al., 1985). In all cases, 
the general L-shaped conformation seen with tRNA^^^ is observed. However, 
in several cases Interesting subtle conformational differences exist. 
In tRNA^^ from E. ooli, a different conformation of the anticodon 
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loop Is observed (Woo et al., 1980). The constant ur1d1ne-33 base 
projects away from the loop, whereas in yeast tRNA***^® it points into the 
loop (Sussman et al., 1978, Fig IB). The different loop conformations 
lead to slightly different stacking arrangements of the anticodon bases in 
the two tRNAs. These observations have led to speculation that the 
conformation of the anticodon loop may be a factor in distinguishing the 
initiator tRNA from elongating tRNAs, and it may have implications 
concerning conformational changes in the anticodon loop during protein 
synthesis (Woo et al., 1980). 
The three-dimensional structure of yeast tRNA^^P revealed that in the 
crystal, the tRNA molecules are associated through their partially self-
complementary anticodons (GUC). Analysis of the thermal vibrational 
motions of the tRNA^^P crystal structure revealed a stabilization of the 
anticodon arm and a destabilization of the T and D loops compared to 
tRNA^^^. The labilization of the interactions between the T and D loops 
is suggested to be a consequence of the interaction of the anticodon trip­
lets in tRNA^^P, and may reflect the conformational state of tRNA inter­
acting with messenger RNA (Westhof et al., 1985). 
Solution structure of tRNA 
Data from numerous investigations of the solution structure of tRNA 
generally agrees with the crystal structure of yeast tRNA^^^. These 
studies include investigation of the susceptibility of tRNAs to a variety 
of nucleases (for review see Rich and RajBhandary, 1976), the exchange of 
tritiated water with H-8 of purines (reviewed by Schimmel and Redfield, 
1980), binding of complementary oligonucleotides to tRNAs to probe for 
single-stranded regions (Uhlenbeck, 1972; Freier and Tinoco, 1975), and 
perhaps most importantly chemical modifications of tRNA (reviewed by 
Hoi brook and Kim, 1983). A recent study comparing the reactivity of yeast 
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tRNA^^P and tRNA^^^ to ethylnitrosourea with the crystal structures of 
both tRNAs, again supports the contention that these molecules have 
similar structures in the crystal and in solution (Romby et al., 1985). 
In addition, a number of physical studies of tRNA in solution such as 
small-angle X-ray scattering (Nilsson et al., 1982), laser Raman spectros­
copy (Chen et al., 1975), and NMR spectroscopy (reviewed by Reid, 1981) 
have confirmed that in general, the solution structure of transfer RNA 
closely approximates that of the crystal structure of yeast tRNA^^^. 
Dynamics of tRNA 
The three-dimensional structure determined by X-ray crystallographic 
methods is a static structure representing the average of a population of 
dynamically fluctuating structures. When tRNA interacts with other macro-
molecules, conformational changes in the tRNA structure are generally 
assumed to take place. A complete understanding of transfer RNA will, 
therefore, involve knowledge of conformational variations and dynamics of 
this molecule alone, as well as in association with other relevant 
biomacromolecules. 
Conformational states iji solution 
The ability of transfer RNA to undergo conformational changes in 
solution has been studied intensively (for review see Crothers and Cole, 
1978 or Rigler and Wintermeyer, 1983). The early studies of Crothers and 
his coworkers established the importance of temperature and counterions in 
determining the conformation of tRNA (Cole et al., 1972). More recently, 
fluorescence studies using tRNA labeled with ethidium in the D loop or in 
the anticodon loop have distinguished three conformational states (Tl, T2, 
T3); the distribution of these states is dependent on Mg"*"*", spermine, and 
temperature (Ehrenberg et al., 1979, Nilsson et al., 1983). T3 is the 
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predominant state at high concentrations of Mg"*"*" and/or spermine, and it 
was concluded that tRNA in this state may have a structure similar to the 
crystal structure of yeast tRNA^^^. 
Further evidence for magnesium and temperature induced conformational 
changes in tRNA has been provided by NMR studies (Salemink et al., 
1980; Gorenstein and Goldfield, 1982). Also, proton and NMR studies 
have provided evidence for two different conformations of the T loop in 
tRNAs in solution (Kastrup and Schmidt, 1975, 1978; Kopper et al., 1983). 
Several other studies have shown that mildly acidic pH can induce confor­
mational transitions in tRNA (Bina-Stein and Crothers, 1975; Steinmetz-
Kayne et al., 1977). 
The biological significance of tRNA conformational changes is not 
well understood, and questions still remain regarding the role of confor­
mational changes of tRNA in protein synthesis. For example, aminoacyl-
tRNA is distinguished from nonaminoacylated tRNA in a number of biological 
processes, including interaction with EF-Tu and ribosome binding, leading 
to speculation that tRNA molecules undergo a conformational change upon 
aminoacylation. However, the effect of aminoacylation on the structure of 
tRNA has been a controversial issue. Some evidence suggests that amino­
acylation causes conformational changes in the tRNA molecule resulting in 
a "more extended" conformation (Potts et al., 1981). Other studies, such 
as NMR analysis of aminoacylated tRNA, have found little or no structural 
alterations upon aminoacylation (Wong et al., 1973; Davanloo et al., 
1979). Also, analysis of crystals of N-acetyl-Phe-tRNA^^^ has revealed no 
significant differences from tRNA^*^^, although small changes could not be 
ruled out (Rich et al., 1980). It seems that if any changes in tRNA con­
formation occur on aminoacylation, they are quite small. 
Although several conformational changes have been proposed to occur 
in tRNA upon codon binding (discussed below), conclusive evidence about 
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the existence of these changes and their role in protein synthesis is not 
yet available. 
Codon-Anticodon Interaction 
Recognition of a codon triplet on messenger RNA by the appropriate 
transfer RNA is one of the most important steps in protein biosynthesis. 
It is, in part, the specificity of this interaction that ensures the 
proper sequence of amino acids in the growing peptide chain. Due to this 
importance, the codon-anticodon interaction has been studied extensively. 
A complete understanding of this process will require detailed knowledge 
of the structure and dynamics of codon-anticodon complexes. 
Interaction of the anticodon loop of tRNAs with oligonucleotide 
codons has been studied by equilibrium dialysis (Uhlenbeck et al., 1970; 
Eisinger and Spahr, 1973; Freier and Tinoco, 1975), fluorescence measure­
ments (Yoon et al., 1975), and recently by NMR (Geerdes et al., 
1980a, 1980b; Clore et al., 1984). Association constants for codon-
anti codon complexes are significantly higher than those for the associa­
tion of complementary tri- or tetranucleotides (Jaskunas et al., 1968), 
implying that some feature of the anticodon loop is involved in stabiliz­
ing the codon-anticodon interaction (Yoon et al., 1975). This concept is 
further supported by the finding that two tRNA molecules with complemen­
tary anticodons can form a complex whose association constant is several 
orders of magnitude greater than that for binding of complementary oligo­
nucleotides (Eisinger, 1971; Grosjean et al., 1976). The ideal base 
stacking of the anti codon in the crystal structure of tRNA^*^^ (Quigley and 
Rich, 1976; also see previous section on tRNA^^^ crystal structure) 
provides some clue to the nature of this improved stability, and several 
studies have shown that the presence of modified bases adjacent to the 
anticodon also stabilizes the interaction with codon (Pongs and Reinwald, 
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1973; Grosjean et al., 1976). 
Conformational changes 
Much conflicting evidence has been presented concerning the possi­
bility of codon-induced conformational changes in tRNA and their role in 
protein synthesis. Two types of structural transitions have been pro­
posed: one in the antlcodon loop Itself, and the other some distance from 
the antlcodon, involving disruption of the tertiary interactions between 
the T and D loops. 
The 3'-stacked conformation of the antlcodon loop seen in the crystal 
structures of several tRNAs was first proposed by Fuller and Hodgson 
(1967). Since then, several models of protein synthesis have proposed a 
transition between the 3'-stacked structure and a conformation with the 
antlcodon stacked on the 5' side of the loop (Uoese, 1970; Crick, 1976; 
Lake; 1977). 
Considerable evidence suggests that the structure of the antlcodon 
loop is flexible and very sensitive to solution conditions, even more 
labile than the tertiary structure of the molecule. The thermal vibra­
tional motions of the nucleotides in the tRNA''^® crystal structure indi­
cate that the antlcodon loop is among the most flexible parts of the mole­
cule (Kim, 1980) Conformational flexibility in this loop has also been 
shown by NMR (Salemink et al., 1980; Gorenstein and Goldfield, 1982). 
These studies show that at high [Mg'*"*'] the antlcodon loop is present in 
two different conformations, and under all conditions, antlcodon loop 
structure is very temperature sensitive. A number of fluorescence studies 
involving the Y base, 3'-adjacent to the antlcodon in yeast tRNA^^^ also 
Indicate that the antlcodon loop may be present in at least two conforma­
tions (Ehrenberg et al., 1979; Wells, 1984). Urbake and Maass (1978) have 
suggested that a relaxation process observed in temperature jump fluorés-
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cence studies of tRNA^^^ Is the result of a conversion between the 3'- and 
5'-stacked conformations. Later studies by Labuda and Porshke (1980) 
Indicate that the codon UUC binds preferentially to one of the two anti­
codon conformations. 
Results of oligonucleotide binding experiments also Indicate that the 
anticodon may be stacked on the 5'-s1de of the loop. In the 3'-stacked 
structure, a sharp U-turn separates the anticodon triplet from the Invari­
ant U-33 located 5' to the anticodon. In this conformation, U-33 Is not 
available for base-pairing with oligonucleotides that are complementary to 
the anticodon and the adjacent 5'-sequence. However, several studies show 
that oligonucleotides which are complementary to U-33 In addition to the 
anticodon, bind significantly more tighly than the corresponding codon 
triplets (Uhlenbeck et al., 1970; Elslnger and Spahr, 1973; Yoon et al., 
1975; Geerdes et al., 1980a). The higher affinity of these tetranucleo-
tldes for the anticodon of a tRNA suggests additional base-pairing between 
the 3'-terminal adenosine and U-33. An alternative explanation for the 
Increased affinity Is that the fourth base of the tetranucleotlde (A), 
rather than base-pairing with U-33, stabilizes the oligonucleotide binding 
by stacking on the preceding base-pair (3'-dangl1ng end effect) (Westhof 
et al., 1983). 
The role of a conversion between the 3'- and 5'-stacked conformation 
of the anticodon in protein synthesis has been challenged In recent years. 
A number of studies. Including detailed analysis of f1uorophore-
derlvatlzed tRNA^^^ (Odom et al., 1978; Paulsen et al., 1982), chemical 
modification (Douthwalte et al., 1983), and photo-cross-1Inking between 
the tRNA anticodon and mRNA (Matzke et al., 1980; Stelner et al., 1984; 
Cleslolka et al., 1985) suggest that the anticodon loop retains the 
conformation seen In crystals. In solution, upon binding to r1bosomes, and 
during the translocation step of protein synthesis. 
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Conformational changes in distant parts of the tRNA molecule have 
been attributed to the association of codon with the anticodon, and in 
particular it has been proposed that the interactions between the T and D 
loops are disrupted as a result of this recognition process (Mol1er et 
al., 1980). This structural rearrangement has been suggested to make the 
conserved TvCG sequence in the T loop available for interaction with a 
complementary sequence in one of several ribosomal RNAs. 5S rRNA was 
first implicated as the site of interaction (Forget and Weissman, 1967; 
Schwarz et al., 1976) but this hypothesis was later discounted by investi­
gations with 5S RNA lacking the complementary binding site (Pace et al., 
1982; Zagorska et al., 1984). Recent studies suggest that 16S rRNA has 
the potential to bind the GTvCG sequence of an elongator tRNA (Hilk and 
Sprinzl, 1985). 
In the crystal structure of yeast tRNA^^e the T loop interacts with 
the D loôp, forming a number of tertiary base-pairs rendering the TvCG 
sequence unavailable for pairing to complementary oligonucleotides. And 
in solution, neither yeast tRNA^he (Pongs et al., 1973) nor tRNA^®^ 
(Freier and Tinoco, 1975) bind CpGpApA. Significant binding of CpGpApA to 
yeast tRNA^he wag shown to occur when (Up)g is present (Schwarz et al., 
1976), which suggests that codon binding causes a conformational change in 
the tRNA that disrupts the interaction between the T and D loops, making 
the TyCG sequence available. The three-dimensional structure of yeast 
tRNA^sp molecules associated through their anticodons reveals a destabil-
ization of the interactions between the D and T loops, and Westhof et al. 
(1985) propose that this is a consequence of the anticodon-anticodon self-
pairing (Westhof et al., 1985). 
Other studies using NMR do not detect any gross conformational 
change in the structure of tRNA^he as a result of codon binding (Geerdes 
et al., 1978). The possibility of codon-induced rearrangement of the T-D 
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loop interactions and its role in protein synthesis remains controversial. 
Codon binding has also been shown to induce association of transfer 
RNA molecules, resulting in the formation of dimers (Porschke and Labuda, 
1982, 1983; Geerdes et al., 1980b) or a complex of 9±2 RNA molecules 
(Clore et al., 1984). This effect appears to be specific for trinucleo­
tide codons. In one case UpUpC binding to yeast tRNA^he resulted in dimer 
formation whereas the tetranucleotide UpUpCpA did not induce association 
(Geerdes et al., 1980b). 
NMR Studies of tRNA 
High resolution nuclear magnetic resonance (NMR) is currently the 
most informative spectroscopic tool available to probe the solution 
conformation and dynamics of tRNA. The particular advantage of NMR is 
that signals can be obtained from nuclei in many parts of the molecule 
simultaneously, and several types of information can be obtained from each 
reporter. Before detailed structural and biochemical information can be 
obtained from NMR studies, resonances in the spectra must be assigned to 
specific nuclei in the molecule. Much of the recent work has been 
concerned with making such identifications, and these studies are opening 
the way for more detailed study of tRNA in solution and of its interaction 
with biologically relevant molecules. 
Two naturally occurring isotopes in RNA, and are amenable to 
NMR studies, and isotope enrichment techniques are being used to study 
other nuclei such as and ^^N. The majority of NMR studies of tRNA 
involve proton NMR; these investigations have centered on the hydrogen-
bonded imino protons (Reid, 1981), and the modified bases in tRNA (Kastrup 
and Schmidt, 1978). Changes in the phosphodiester backbone of tRNA can be 
monitored using NMR (Salemink et al., 1980; Gorenstein and Goldfield, 
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1982), and NMR has been used to study both the methylated bases 
(Kopper et al., 1983; Smith et al., 1985) and the major constituents of 
tRNA (Schwelzer et al., 1984; Schmidt et al., 1983) Recently, NMR has 
been used to study the conformation of pseudouridine in several tRNAs 
(Griffey et al., 1985). A brief description of several applications of 
NMR to study tRNA follows. Several excellent recent reviews may be 
consulted for more detailed information on this subject (Schimmel and 
Redfield, 1980; Reid, 1981; Rigler and Wintermeyer; 1983). 
Assignment of proton resonances 
Major advances in assignment of the imino protons in low-field NMR 
spectra of tRNA have been made recently using nuclear Overhauser effect 
(NOE) experiments (Reid, 1981; Roy and Redfield, 1983; (Hyde and Reid, 
1985). Two dimensional NOE experiments have even resulted in the complete 
assignment of the imino proton resonances in the spectra of phenylalanine 
tRNA from yeast (Hilbers et al., 1983) and E. ooli tRNAj®^ (Hare et al., 
1985). Assignment of the high-field methyl spectra has been accomplished 
by comparing the NMR spectra of tRNA at high temperature with that of 
model methylated nucleosides. The assigned peaks are then traced back to 
their native chemical shifts by lowering the temperature. With reliable 
assignments the interaction of tRNA with other molecules such as cations, 
codons, and enzymes can be studied and Interpreted using proton NMR. 
Melting 
Thermal denaturation of tRNA has been the subject of several NMR 
studies. Kastrup and Schmidt (1975, 1978) monitored the sequential 
thermal unfolding of tRNAj®^ using ^H NMR of modified bases. Three separ­
ate structural transitions are observed as the temperature is increased: 
disruption of tertiary structure, changes in the anticodon stem, and 
finally melting of the TvC helix. Evidence also supports the existence of 
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multiple conformations of the ribothymidine residue at temperatures below 
the (Kastrup and Schmidt, 1978). 
The thermal unfolding sequence of tRNA^he has recently been studied 
using imino proton exchange (Johnson and Redfield, 1981; Roy and Redfield, 
1983). In the absence of magnesium, acceptor stem and tertiary resonances 
melt almost concurrently followed by the dihydrouridine stem; in high 
[Mg**] the D stem becomes the most stable helical structure. At low 
temperature, the acceptor stem shows increased lability at both ends, 
indicating that individual stems do not necessarily melt in a concerted 
fashion. These studies also show that tertiary interactions in tRNA are 
not always the most labile as previously assumed. Similar observations 
have been made with E. ooti tRNA^^^ by Reid (1981) where the anticodon 
helix melts before unfolding of tertiary structure occurs. 
Ion binding to tRNA 
Addition of magnesium to tRNA causes pronounced shifting of some low-
field resonances in NMR spectra (Reid, 1981). Recent studies by Hyde 
and Reid (1985) with E. coli tRNA^he show effects of Mg** on resonances 
from all stems of the molecule, but different effects are observed for 
different peaks. The tightest binding site observed is near U12-A23. 
These studies also show that at low [Mg**] tRNA^he exists as a mixture of 
two conformations in slow exchange, differing at positions 12 and 13 in 
the D stem. 
The binding of Mn** to tRNA has been studied via its paramagnetic 
relaxation effects. This ion binds in the hinge region between the D and 
T loops of tRNA^he, gg determined crystallographically (Jack et al., 1977; 
Quigley et al., 1978). Chao and Kearns (1977) have interpreted selective 
broadening of proton NMR signals by Mn** in the spectrum of yeast tRNA^he 
to reflect sequential Mn** binding at several sites in the order s^U8-A14, 
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U33, and G19-C56. Hurd et al., (1979) investigated several tRNAs at lower 
Mn** levels and found a single site close to the s^8-A14 tertiary base-
pair. NMR studies of [4-^^C] uracil labeled tRNAj®^ show that the 
dihydrouridine residue at position 17 was affected by Mn"*^ before the 
s^U-8 peak (Schweizer, 1980). 
Contrasting the previously mentioned studies, which indicate discrete 
cation binding sites, NMR studies by Gueron and Leroy (1982) indicate 
very similar Mn** lifetimes on all phosphates with no specific tight bind­
ing sites. 
Spermine binding to E. ooll tAWA^he has been reported to mainly 
affect NMR resonances from base pairs G15-C48 and s^U8-A14 (Hyde and 
Reid, 1985), whereas Gorenstein and Goldfield (1982) found a major effect 
of added spermine on the resonances from anticodon residues in yeast 
tRNA^he. Two bound spermine molecules are found in the X-ray structure of 
tRNA^he, one in the anticodon helix and a second near the D stem, (Quigley 
et al., 1978, see Figure IB). 
Interaction with proteins 
One ultimate goal of NMR studies of tRNA is analysis of tRNA recogni­
tion by specific enzymes. Schulman and co-workers (1975) investigated the 
effects on the NMR spectrum of E. ooli tRNA®^" of binding Glutamyl-tRNA 
synthetase and the elongation factor EF-Tu. Conducted at 25°C, these 
studies produced very broad unresolved spectra upon complex formation with 
either protein. The authors concluded, however, that the tRNA does not 
change its secondary structure upon binding to either protein since no 
base-pairs were broken. 
More recently, advantage has been taken of thermophilic synthetase 
enzymes that are stable up to 65°C. Schweizer and co-workers (1984) 
studied the cognate complex between [4-^^C] uracil-labeled E. ooli tRNAj^l 
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and B. etearothexmopHlua valyl-tRNA synthetase (VRS). The greatest 
effects of this interaction were on peaks assigned to s^U8, rT54, and 
V34, suggesting that VRS is in contact with the anticodon, D, and T loops. 
Incorporation of 5-Fluorouracil into Transfer RNA 
The pyrimidine analog 5-fluorouracil (FUra) was first synthesized in 
1957, primarily as a potential drug for the treatment of cancer 
(Duschinsky et al., 1957). The primary mechanism of the anticancer activ­
ity of FUra is generally believed to involve inhibition of thymidylate 
synthetase by the in vivo 5-fluorouracil metabolite, 5-fluoro-2'-deoxyuri-
dine 5'-monophosphate (FdUMP) (Myers, 1981). FdUMP acts as a suicide 
inhibitor of thymidylate synthetase, giving rise to a stable structure 
resembling a transient intermediate in the normal enzyme reaction (Abeles 
and Maycock, 1980). This interaction has been of great value in studying 
the mechanism of thymidylate synthetase activity. 
Under certain conditions FdUTP is formed and can be incorporated into 
DNA (Major et al., 1982). Also, in many systems FUra is converted to 5-
fluorouridine 5'triphosphate and incorporated into RNA (Horowitz and 
Chargaff, 1959). The complex metabolism and biochemical mechanisms of 5-
fluorouracil action were recently reviewed by Heildelberger et al. (1983). 
5-Fluorouracil is incorporated into bacterial transfer RNAs (Horowitz 
and Chargaff, 1959) as a substitute for uridine and uridine-derived minor 
nucleosides (Lowrie and Bergquist, 1968; Johnson et al., 1969; Kaiser, 
1972). Under certain conditions this replacement can be essentially 
complete resulting in substituted tRNAs that lack modified nucleosides 
such as pseudouridine, ribothymidine, 5,6-dihydrouridine, and 4-thiouri-
dine (Lowrie and Bergquist, 1968; Johnson et al., 1969; Kaiser, 1969). 
Studies of FUra-substituted transfer RNA have been conducted to investi-
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gate the effects of FUra replacement on the structure and biological func­
tions of these molecules and to study the role of modified nucleosides In 
transfer RNA activity. 
Unfractlonated FUra-containIng tRNA from E. aoli Is able to accept 
all amino acids (Lovyrie and Bergquist, 1968; Johnson et al., 1969; Kaiser, 
1969). However, several (FUra)tRNAs are aminoacylated at significantly 
lower rates and to lower extents than their normal counterparts (Ramberg 
et al., 1978). Lysine tRNA is the most inhibited, being only 6% as active 
as normal tRNA^ys, FUra-substituted Lys-tRNA^ys is also impaired in its 
ability to bind to ribosomes and function in polypeptide synthesis 
(Ramberg et al., 1978). Aminoacylation with aspartate, glutamate, gluta-
mine, and histidine is also inhibited. All these analogue-substituted 
tRNAs with reduced activity contain a 5-fluorouridine residue in the 
second position of their anticodons, and this substitution may be, at 
least in part, responsible for their lowered activities (Ramberg et al., • 
1978). 
With the few exceptions noted above, FUra-substituted tRNAs from E. 
aoli appear to be fully functional in protein synthesis. Examined in 
detail, the properties of purified FUra-substituted valine tRNA have been 
found to differ little from normal tRNAj®^ (Ofengand et al., 1974). 
(FUra)tRNA2®^ is aminoacylated with similar kinetics as normal tRNA-[®^ 
(Horowitz et al., 1974). Ternary complex formation with EF-Tu-GTP, non-
enzymatic binding to the ribosomal P-site, EF-Tu-dependent binding to the 
ribosomal A-site, and polypeptide synthesis all occur normally with FUra-
substituted tRNAi*^ (Ofengand et al., 1974). These studies clearly demon­
strate that in every biological function tested, FUra-substituted tRNAj®^ 
retains full activity. Furthermore, FUra-containing tRNA is fully func­
tional in the tRNA-dependent synthesis of pppGpp in the stringent response 
(Chinali et al., 1978). (FUra)tRNAf®^ has also been found to be fully 
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active with regard to aminoacylation and formulation (Hills et al., 1983). 
Incorporation of FUra also has little effect on the physical prop­
erties of tRNAj®^, including the temperature-absorbance melting profile, 
circular dichroism spectra, and electrophoretic mobility in polyacrylamide 
gels (Horowitz et al., 1974). FUra-substituted tRNAj®^, therefore, 
represents an ideal system for studies of transfer RNA structure and func­
tion by ^®F NMR. Most of the studies presented here involve this tRNA. 
^^F NMR Studies of FUra-Substituted tRNA 
^®F NMR provides a powerful probe of the solution structure and 
dynamics of FUra-substituted tRNA. Advantages of using fluorine-19 in NMR 
spectroscopy include; high sensitivity of detection, 100% natural abun­
dance, a large range of ^®F chemical shifts, and extreme sensitivity of 
^®F chemical shifts to the environment of the nucleus. Also, ^^F NMR 
spectroscopy of fluorinated tRNAs is ideally suited for investigation of 
tRNA-protein interactions without interference from protein signals. 
Prior to this study, ^®F NMR spectra of two purified FUra-substituted 
E. ooU tRNAs, tRNA^al (Horowitz et al., 1977) and tRNA^et (Hills et al., 
1983) had been obtained. Cloverleaf structures of these analogue substi­
tuted tRNAs, along with FUra-substituted tRNAjJJ®^, (purified in this 
study), are shown in Figure 2. FUra residues occur in virtually every 
stem and loop of these tRNAs, and each can serve as a reporter of struc­
tural changes in its vicinity. 
Representative 282 MHz ^^F NMR spectra of (FUra)tRNA][®^ and 
(FUra)tRNAf®^ are shown in Figure 3A and 3B, respectively; also indicated 
are the relative areas of each region of the spectra, obtained by inte­
gration on the spectrometer, and the peak designations. Spectra of 
(FUra)tRNAi*1 (Fig. 3A) show 11-12 resolved resonances for the 14 incorpo-
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Figure 2. Nucleotide sequence (cloverleaf structure) of E. coli tRNAj®^, tRNA^®^, and tRNA{jJ®^ with 
uracil and uracil-derived nucleosides replaced by 5-fluorouracil (F). The bases 
substituted by FUra which are invariant in all tRNAs (see Fig. lA) are enclosed in boxes. 
FUra residues involved in tertiary hydrogen bonds with other nucleosides, based on the 
crystal structure of yeast tRNA^^e (see Fig. IB), are connected by solid lines 
Figure 3. ^®F NMR spectra of 5-fluorouracil-substituted tRNA-[®^ (A) 
and tRNAf®^ (B). The spectra were recorded at 282 MHz at 
25°C with tRNA in 50 mM sodium cacodylate buffer, pH 6.0, 
containing 15 mM MgClg» 10 mM NaCl, 1 mM EDTA, and 10% ^WgO 
as an internal lock. Chemical shifts are given in ppm from 
5-fluorouracil. Areas obtained by integration on the 
spectrometer, and peak designations are indicated 
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rated FUra residues in the molecule (Fig. 2), and 9-10 resolved peaks are 
seen in spectra of (FUra)tRNAf®^ (Fig. 3B) from the 12 FUra residues in 
this fluorinated tRNA (Fig. 2). 
The ^®F resonances in each spectrum are distributed over a large 
range of chemical shift positions, from ca. 0.5 to 8.0 ppm dowmfield from 
the standard free FUra (= 0 ppm). Comparison of the two spectra (Fig. 3A 
and 3B) shows that while there are similarities, each tRNA yields a unique 
characteristic spectrum. One notable similarity between the spectra is 
that in each case the peaks can be grouped into three categories based on 
chemical shift position. Each spectrum contains a central cluster of 
resonances between ca. 3.8 and 5.0 ppm, several resolved resonances 
located downfield from 5 ppm, and a number of peaks upfield from the cen­
tral cluster. Evidence has been presented (Horowitz et al., 1977; Hardin, 
1984; Hardin et al., 1986) supporting the hypothesis that these groupings 
correspond to FUra residues in three distinct structural environments in 
the tRNA molecule: hydrogen-bonded bases in helical domains (upfield), 
non-hydrogen-bonded bases in loops (central), and FUra residues participa­
ting in tertiary interactions (downfield). 
FUra-containing tRNA^®^ and tRNAj®^ can be separated into two isoac-
cepting species termed the A and B forms (Hills et al., 1983; Hardin, 
1984). ^®F NMR spectra of the two forms differ by the shift of one ^^F 
peak from ca. 4.5 to 4.8 ppm in isoacceptor B, upfield to -15 ppm in 
isoacceptor A. Further studies have demonstrated that the peak at ca. -15 
ppm is due to a ring-opened fluorodihydrouridine substituent in the A form 
of these tRNAs (Horowitz et al., 1983). Apparently, the enzyme that 
normally reduces uridine to dihydrouridine is capable of recognizing 5-
fluorouracil to some extent, and reduces it to fluorodihydrouridine. This 
is the only known example of enzymatic recognition and modification of 5-
fluorouridine in tRNA. 
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In the A form of (FUra)tRNA^®^, the modified FUra was shown to be 
located at position 20, normally occupied by 5,6-dihydrouridine (Hills et 
al., 1983). This finding allowed assignment of a resonance at 4.8 ppm in 
the ^^F NMR spectrum of (FUra)tRNA%et to FUra-20 (Hills et al., 1983). 
It has been suggested that a similar situation exists in (FUra)tRNA-[®^, 
with the modified FUra in the A form being located at the site of the only 
dihydrouracil in the molecule (position 17), but conclusive evidence was 
not available (Hardin, 1984). 
Several other preliminary peak assignments in the ^^F NMR spectrum of 
(FUra)tRNAj®^ have been made (Hardin, 1984). However, most of the reso­
nances remain unassigned, and need to be assigned to allow interpretation 
of spectral changes at the molecular level. 
In this study, FUra-substituted tRNA}J}®^ was purified, its ^®F NMR 
spectrum obtained and then compared to those of (FUra)tRNAf®^ and 
(FUra)tRNAj®^. The effects of pH, ion binding, and temperature on the ^^F 
NMR spectra of FUra-substituted tRNA were also examined. Reaction of 
FUra-containing tRNA with bisulfite and psoralens was investigated as a 
means for assigning peaks in the spectra. Finally, codon-antlcodon inter­
action in FUra-substituted tRNA was examined in detail by ^^F NMR 
spectroscopy. 
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EXPERIMENTAL PROCEDURES 
Materials 
5-fluorouracil was donated by Hoffmann-LaRoche, and calcium leuco-
vorin was a gift from Lederle Laboratories. Eeoheviahia ooli strain B was 
supplied by Grain Processing Corporation, Muscatine Iowa. Sephacryl S-
200, Sepharose 4B, DEAE-Sephadex A-50 and A-25 were all purchased from 
Pharmacia. BD-cellulose and Bio-Gel P2 were supplied by Bio-Rad Labora­
tories, DEAE-cellulose (DE-32) was a Whatman product, and cellulose thin-
layer sheets (5502) were from EM Laboratories. RPC-5 adsorbant was 
prepared according to Method C of Pearson et al. (1971) using Adogen 464 
(Ashland Chemical Co.) and Plaskon CTFE 2300 powder (Allied Chemical Co.), 
which were gifts of Dr. Ivan Kaiser, Dept of Biochemistry, University of 
Wyoming, Laramie WY. Adenosine S'-Cy-^Zp] triphosphate was purchased from 
New England Nuclear. Radioactive amino acids were obtained from New 
England Nuclear or ICN, and ^H-labeled KBH^ was from Amersham Corp. Sper­
mine tetrahydrochloride was purchased from Calbiochem Inc. Ribonuclease H 
was a product of Bethesda Research Laboratories. Polynucleotide phosphor-
ylase, calf intestinal phosphatase (Molecular Biology Grade), and GpU were 
from Boehringer Mannheim. Ribonuclease Tj, Ribonuclease A, Pyrophosporyl 
chloride, Pyronin Y, ApApA, UpApA, and CpG and ribonucleosides were all 
obtained from Sigma. E. coli tRNA^/^ with a specific activity of 1450 
pmol/A26o» was from Subriden RNA, Bacterial alkaline phosphatase (BAPF) 
and snake venom phosphodiesterase were purchased from Worthington 
Biochemical Corp. T4 RNA ligase and polynucleotide kinase were products 
of P and L Pharmacia Biochemical s. Eastman-Kodak X-Omat XAR-5 film was 
used for fluorography and autoradiography. The scintillators 2,5-diphen-
yloxazol (PPO) and l,4-bis-[2-(5-phenyloxazol)]-benzene (POPOP) were 
Fischer products as were acrylamide and N,N-methylene bisacylamide which 
were recrystallized from acetone prior to use. Sodium cacodylate and 
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deuterium oxide (99.8%) were from Aldrich. All other reagents were of 
analytical grade or better. 
The lO-formyltetrahydrofolate used in formlyation assays was prepared 
by the method Dubnoff and Maitra (1971). Calcium leucovorin (5-formyl-
tetrahydrofolate) was converted to 5,10-methyltetrahydrofolate by incuba­
tion at room temperature, in the dark, with 0.1 M HCl for 4 h. This 
product was stored at -20°C and converted to 10-formyltetrahydrofolate by 
treatment with 40 mM Tris-HCl, pH 8, and 80 mM KOH just prior to use. 
3',5'-Nucleoside bisphosphates used in RNA ligase catalyzed synthesis 
of oligonucleotides were prepared from the corresponding nucleosides and 
pyrophosphoryl chloride by the method described by Barrio et al., (1978). 
A mixture of nucleoside (0.15 mmol) and pyrophosphoryl chloride (1.5 mmol) 
was stirred at -10°C in an ethanol/ice bath. After 4 h, the reaction was 
quenched by addition of ice and 5-10 mL of 0.5 M TEAB, pH 8.0. The solu­
tion was evaporated to dryness under vacuum at 30°C and the residue was 
then dissolved in 50% methanol and evaporated to dryness. This step was 
repeated several times to remove all remaining TEAB. The resulting 
bisphosphates were purified by chromatography on a column of DEAE-cellu-
lose (2.3 X 36 cm) using a linear gradient of 50 to 400 mM TEAB, pH 8.0. 
Yields were 50-90% of an unresolved mixture of nucleoside 2',5'- and 
3',5'-bisphosphates, as judged by NMR. This mixture was used directly 
in ligation reactions because the 2',5'-bisphosphates do not serve as 
either substrates or as competitive inhibitors (England and Uhlenbeck, 
1978). 
All glassware was baked at 140°C for 6 h or longer and water was 
autoclaved to minimize nuclease activity. Phenol was distilled prior to 
use to remove impurities, and then stored at 4°C in the dark. Dialysis 
membranes were from Bethesda Research Laboratories and had been treated to 
remove heavy metal contaminants. The membranes were stored in 25% ethanol 
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with 1 mM sodium azide and were washed thoroughly with autoclaved water 
prior to use. Transfer RNA concentrations were determined from spectro-
photometric measurements at 260 nm assuming a value of = 24. 
Methods 
Growth of g. ooli cells in the presence of 5-fluorouracil 
Eaaheriahia ooli strain B was grown at 37°C in a minimal glucose-
salts medium (Demerec and Cahn, 1953) in 15 L glass carboys with aeration. 
When the cells reached exponential growth, 5-fluorouracil and thymidine 
were added at a final concentration of 25 mg/L each. After incubation for 
3 hr, the cells were concentrated with an Ami con Pell icon system and 
collected by centrifugation for 10 min at 4000 x g in a Beckman J2-21 
centrifuge (JA-10 rotor). Cells were then washed twice with 10 mM Tris-
HCl, pH 7.4, 10 mM magnesium acetate and stored at -20°C. Yields were 20-
35 g of cell paste/15 L culture. 
tRNA preparation 
Unfractionated RNA was prepared from FUra-treated bacteria by phenol 
extraction of whole cells as described by Zubay (1966). After the phenol 
treatment, the RNA was precipitated from the aqueous phase by addition of 
0.1 volume of 20% potassium acetate, pH 5.0 and two volumes of ethanol. 
The precipitated RNA was stored at -20°C at least 1 h, collected by 
centrifugation at 10,000 x g for 10 min, and then dissolved in 300 mM 
sodium acetate, pH 7.0, at a concentration of 2.5 mg/mL. High molecular 
weight RNA (16S and 23S rRNA) was removed from the preparation by precipi­
tation with isopropyl alcohol (0.54 volumes) at 20°C (Zubay, 1966). Con­
taminating 5S rRNA was removed from the tRNA by gel filtration on 
Sephacryl S-200 (2.5 x 235 cm) at room temperature, using 0.5 M NaCl in 
0.14 M sodium acetate buffer, pH 4.5, as eluant (Horowitz et al., 1974). 
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Purification of FUra-substituted tRNA^^t 
5-fluorouracil-substituted tRNAj^®^ was purified using minor modifi­
cations of the procedure described by Hills et al. (1983) for the puri­
fication of FUra-substituted initiator methionine tRNA. This method 
involves a series of column chromatography steps. The methionine tRNA-
containing fractions from each column were located by aminoacylation assay 
using ^H-L-methionine, pooled, and the RNA collected by precipitation with 
ethanol. The specific activity of the tRNA from each column was deter­
mined by assaying for acceptance of ^^C-L-methionine. 
FUra-containing tRNA was separated from unsubstituted tRNA by ion 
exchange chromatography on DEAE-cellulose (5 x 750 cm) at pH 8.9 (Kaiser, 
1969). The column was developed at room temperature with a concave NaCl 
gradient from 0.325 M (6 L) to 0.6 M (2 L) in 20 mM Tris-HCl, pH 8.9. 
Fractions containing methionine tRNA were pooled and assayed for the abil­
ity to be formylated, in order to distinguish between tRNA^ct and initi­
ator tRNA^Gt, 
FUra-substituted tRNAjJj®^ was then further fractionated by chromatog­
raphy at 5°C on a Sepharose 4B column (2 x 94 cm) using a reverse ammonium 
sulfate gradient from 1.5 M to 0.0 M (NH4)2S04 (Holmes et al., 1975; 
Colantuoni et al. 1978). The pooled tRNA^®^-containing fractions were 
desalted on DEAE-cellulose as described by Gillam and Tener (1980), and 
the RNA was then further purified on DEAE-Sephadex A-50 (1.5 x 150 cm) at 
room temperature using a 2 L linear gradient from 0.425 M to 0.500 M NaCl 
in 20 mM Tris-HCl, pH 7.5, and 8 mM MgCl2 (Nishimura, 1971). A final 
purification step involved chromatography at 5°C on benzoylated DEAE-
cellulose (0.9 X 125 cm) using a 500 mL linear gradient from 0.4 to 1.0 M 
NaCl in 10 mM sodium acetate, pH 4.5, and 10 mM MgCl2. This step sepa­
rated two isoaccepting forms of the FUra-substituted tRNAjJ}®^. Only a 
minimal further purification of either form of the tRNA was achieved by 
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reverse phase chromatography on RPC-5 (Pearson et al., 1971) using a 0.9 x 
66 cm column developed with a 500 mL linear gradient from 0.5 M to 1.0 M 
NaCl in 10 mM sodium acetate, pH 4.5, and 10 mM MgCl2. 
Purification of FUra-substituted tRNAf^t 
Purified FUra-containing initiator methionine tRNA was prepared as 
previously described (Hills et al., 1983), using techniques similar to 
those outlined for the purification of (FUra)tRNAjJ®^. Briefly, the proce­
dure involved chromatography on DEAE-cellulose, Sepharose 4B, and DEAE-
Sephadex A-50. BD-cellulose was used to separate the A and B forms of 
FUra-substituted tRNA^®^. Both isoacceptors had specific activities of 
over 1400 pmol/A26Q, and were formylated to the extent of 111% (form-A) 
and 92% (form B). 
Purification of FUra-substituted tRNA-[®^ 
tRNAj®^ was purified from 5-fluorouracil treated E. aoli by minor 
modifications of the procedure described previously for purification of 
FUra-containing methionine tRNAs. In outline, the method involves DEAE-
cellulose chromatography at pH 8.9, followed by chromatography on 
Sepharose 4B and finally BD-cellulose. The purified tRNA accepted over 
1400 pmol l^C-L-valine per A260 unit. FUra-substituted tRNAj®^ was 
resolved into two isoaccepting forms, (A) and (B), on an RPC-5 reverse 
phase chromatography column (Pearson et al., 1971), as described by Hardin 
(1984). Unless the two forms were required separately, a mixture contain­
ing mostly form B, obtained after BD-cellulose chromatography, was used in 
these studies. 
Aminoacylation assay 
Methionine or valine acceptance activity of tRNA samples was measured 
in 100 mL reactions containing 100 mM HEPES, pH 7.5, 20 mM magnesium 
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acetate, 10 mM KCl, 10 mM ATP, 1 mM dithiothreitol, 300 ng/mL partially 
purified aminoacyl-tRNA-synthetases (Meunch and Berg, 1966), 60-80 nM 
radiolabeled amino acid (either ^^C-labeled, specific activity 50 mCi/mmol 
or ^H-labeled, specific activity 0.2-1.0 Ci/mmol), and varying amounts of 
tRNA. Reactions were incubated 30 min at 37°C, and stopped by addition of 
ice cold 5% trichloroacetic acid. The mixtures were incubated on ice for 
10 min, the precipitates were collected on Millipore filters (0.45 nm pore 
size), washed twice with cold 5% trichloroacetic acid, dried and counted 
in a Beckman LS 100 or LS 7500 liquid scintillation counter, using a tolu­
ene based scintillation cocktail containing 0.5% PRO and 0.01% POPOP. 
Formylation assay 
Assays for the formylation of methionyl-tRNA were carried out by 
aminoacylating the tRNA in the presence of the formyl donor 10-formyl-
tetrahydrofolate and treating a portion of the reaction with Cu** at pH 
5.5. Under these conditions, unformylated methionyl-tRNA is hydrolyzed, 
but formylmethionyl-tRNAfCt is stable (Schofield and Zamecnik 1968). 
Transfer RNA samples were aminoacylated as described previously for amino-
acylation assay in a 500 iiL reaction mixture containing 600 liM 10-formyl-
tetrahydrofolate. Sufficient transformylase was present in the partially 
purified synthetase preparation to catalyze formylation. A portion of the 
product was incubated with 10 mM CuSO^ in 0.2 M sodium acetate, pH 5.5, 
for 20 min at 37°C. The tRNA was then precipitated with cold trichloro­
acetic acid and counted as described for the aminoacylation assay. The 
extent of formylation was determined by comparing the extent of aminoacyl­
ation before and after incubation with Cu**. 
Analysis of nucleoside composition 
The nucleoside composition of tRNA and oligonucleotide preparations 
was analyzed by the tritium derivative method of Randerath et al. (1980). 
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RNA samples were first hydrolyzed to nucleosides by incubation for 6 h at 
37°C in a mixture of 0.20 ug/nL ribonuclease A, 0.20 wg/pL snake venom 
phosphodiesterase and 0.16 wg/wL bacterial alkaline phosphatase in 30 mM 
sodium bicine buffer, pH 8.0, containing 10 mM MgCl2. Following diges­
tion, a portion of the mixture was oxidized with 1.2 mM NalO^ for 2 h at 
room temperature in the dark. The resulting nucleoside dialdehydes were 
reduced to ^H-labeled nucleoside trialcohol s by incubation with 10 mM 
[^H]-KBH^, 3Ci/mmol, for 2 h in the dark at room temperature. Excess 
borohydride was then destroyed by addition of 5 N acetic acid, and the 
samples were dried over KOH pellets in a vacuum desicator. 
The mixture of ^H-labeled nucleoside trialcohols was separated by two 
dimensional chromatography on a cellulose thin-layer sheet. Development 
of the first dimension was with a solvent system composed of acetonitrile, 
ethyl acetate, 1-butanol, 2-propanol, and 6 N ammonium hydroxide 
(7:2:1:1:2.7). After drying, a wick of Whatman #1 paper was attached to 
the top of the second dimension and the plates were then developed with a 
solvent system composed of t-amyl alcohol, methyl ethyl ketone, acetoni­
trile, ethyl acetate, H^O, and formic acid (40:20:14:20:14:1.8). 
The separated tritium-labeled nucleoside derivatives were located by 
low-temperature fluorography. Chromatograms were coated with 16 mL of 7% 
PRO in ethyl ether, and stapled to X-ray film. The films were exposed for 
24-72 h at -80°C. Developed films were then used to locate the ^H-labeled 
nucleoside trialcohols whose identity was determined by their migration 
pattern (Randerath et al., 1980). The labeled nucleoside derivatives were 
excised and extracted from the chromatogram with 2M aqueous ammonia, and 
quanti tated by liquid scintillation counting. Because this procedure 
results in a stoichiometric incorporation of tritium into the nucleosides, 
the base composition of the RNA can be determined from the radioactivity 
of the individual nucleoside trialcohols. 
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Polyacrylamide gel electrophoresis 
Electrophoresis of tRNA samples was carried out in 15% polyacrylamide 
gels (acrylamiderbisaoylamide, 20:1) prepared in electrophoresis buffer 
consisting of 100 mM Tris-borate, pH 8.3, 2 mM EDTA containing 5M urea. 
Dimensions of the gels were either 1.5 x 120 x 150 mm (slab gels), or 0.4 
X 300 X 310 mm (sequencing gels). Gels were polymerized by addition of 
0.1% (w/v) ammonium persulfate and 0.01% N,N,N',N'-tetramethylethylenedi-
amine. RNA samples were mixed with an equal volume of electrophoresis 
buffer containing 0.1% bromophenol blue and 0.1% xylene cyanol in 8M urea, 
heated to 90°C for 30 sec, and applied to the gel using glass capillary 
tubes. Electrophoresis was carried out at room temperature in the same 
buffer without urea for 2-6 h at 12 mA for small gels, or at 1000-1500 V 
for sequencing gels. RNA bands in the gels were detected by autoradio­
graphy using X-ray film, for radioactively labeled tRNAs, or by staining 
overnight with 1% pyronin Y in 15% (v/v) acetic acid followed by destain-
ing in several changes of 7.5% (v/v) acetic acid, for unlabeled samples. 
5' End labeling tRNA with 
Transfer RNA was labeled at the 5' end using polynucleotide kinase 
and [y-^^P]ATP. The RNA was first dephosphorylated, by treatment with 
calf intestinal phosphatase, in 10 nL reactions containing 160 pmol of 
RNA, 50 mM Tris-HCl, pH 8.0, and 0.1 units of phosphatase. Reactions were 
incubated 30 min at 55°C, then terminated by addition of 5 mM nitrilotri-
acetic acid followed by incubation for 20 min at room temperature and then 
heating to 100°C for 3 min. For 5'-end labeling, 80 pmol of dephosphory­
lated RNA was dissolved in 10 iiL containing 25 mM Tris-HCl, pH 8.0, 
containing 12.5 mM MgCl2» 10 mM dithiotheitol, 1 mM spermidine, 100 pmol 
[Y_32p]ATp (2500 Ci/mmol), and 1 unit of T4 polynucleotide kinase. The 
reactions were incubated for 30 min at 37°C, and terminated by heating to 
100°C for 3 min. 
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5'-32p_tRNA was purified by preparative polyacrylamide gel electro­
phoresis in 15% polyacrylamide/SM urea gels (1.5 x 120 x 150 mm) as 
described in the previous section. Twenty to 40 pmol of labeled RNA were 
loaded into each lane. A strip of DEAE-cellulose paper was placed beneath 
the slab gel in the anode buffer chamber to trap unincorporated [y-^^P]ATP 
as it ran off the bottom of the gel. Following electrophoresis, radio­
active ink was applied to the corners of the gel and autoradiography was 
used to locate intact labeled tRNA. The gel was covered with plastic wrap 
and exposed to X-ray film for 30 sec. The developed X-ray film was then 
used as a template to cut out the band of intact tRNA from the gel. 
32p-Labeled tRNA was recovered for the polyacrylamide gel by a crush 
and soak procedure. The excised gel slice was placed in a 1.5 mL plastic 
centrifuge tube and crushed into a paste using a siliconized glass rod. 
One-half mL of elution buffer, consisting of 500 mM ammonium acetate, 0.1% 
sodium dodecyl sulfate, 0.001% Triton X-100, and 40 ng/mL unlabeled 
carrier tRNA, was added and the mixture was incubated overnight at room 
temperature with agitation. Polyacrylamide was removed by filtration 
through a quick-sep column (Isolab QS-P) and the extracted RNA was precip­
itated by addition of 1.0 mL cold ethanol. After incubation at -70°C for 
1 h, the precipitated RNA was recovered by centrifugation for 10 min at 
14,000 X g in a microcentrifuge, washed with 0.5 mL of 95% ethanol, dried, 
and resuspended in 20 uL of water. 
Aniline cleavage of tRNA 
Aniline buffered at pH 4.5 with acetic acid induces strand scission 
at depurinated or depyrimidinated sites in RNA by catalyzing a B-elimi-
nation reaction at the position of the damaged base (Peattie, 1979). 
Localization of the open-ring, modified fluorodihydrouracil residue in the 
A form of FUra-substituted tRNA was accomplished using aniline treatment 
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and analysis of the resulting fragments by electrophoresis on sequencing 
gels. Samples containing ca. 1 nCI of 5'-^^P end-labeled tRNA and 2 pg of 
unlabeled carrier tRNA were incubated in 20 nL of 1 M aniline/acetate 
buffer, pH 4.5, at 60°C for 30 min. Reactions were terminated by freezing 
at -70°C, and lyophilizing to dryness. The samples were then redissolved 
in 20 mL of water, frozen and lyophilized to dryness twice more to remove 
all traces of aniline/acetate. The reactions were analyzed by polyacryl-
amide gel electrophoresis on sequencing gels as described previously. 
Control samples were incubated in 50 mM sodium acetate, pH 4.5, without 
aniline. 
Ribonuclease H reactions 
Conditions for RNase H digestions were based primarily upon those of 
Donis-Keller (1979) as modified by T. G. Lawson and H. L. Wieth of Purdue 
Univ. (personal communication). Each reaction was 10 nL in volume and 
contained (unless otherwise indicated) ca. 0.3 pmol of end-labeled 
tRNA, 30-120 pmol of synthetic dGTAA, 40 mM Tris-HCl, pH 7.9, 4 mM MgClg, 
1 mM dithiothreitol, 30 ng/mL bovine serum albumin, and 0.5 units of 
RNase H. Control reactions included all components except the deoxyoligo-
nucleotide or RNase H. Digestions were allowed to proceed for 30 min at 
30°C and terminated by freezing at -70°C, after addition of 10 nL of 8M 
urea containing 0.1% bromophenol blue and 0.1% xylene cyanol. Samples 
from the RNase digestion were analyzed by electrophoresis on polyacryl-
amide gels as described previously. 
Limited ribonuclease T1 digestion of tRNA 
A partial RNase T1 digestion of 5'-^^P-tRNA was used to generate a 
nested set of labeled fragments, each extending from the 5'-end to an 
internal guanosine residue. The procedure was based on that of Donis-
Keller et al. (1977). Approximately 1 pCi of labeled tRNA was incubated 
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in 5 wL of a mixture consisting of 20 mM sodium citrate, pH 5.0, 1 mM 
EDTA, 7 M urea, 0.45 ng/|iL unlabeled carrier tRNA, 0.025% bromophenol 
blue, 0.025% xylene cyanol, and either 0.4 or 0.04 units of RNase T^. 
Control reactions included all components except the ribonuclease. The 
mixtures were incubated at 50°C for 15 min and the digestion stopped by 
immersion in ice. 
Bisulfite modification of FUra-substituted tRNA-[®^ 
The conditions for bisulfite modification of (FUra)tRNA][®^ were those 
described by Schulman and Pelka (1977). FUra-substituted tRNAj®^ was 
dissolved in 2M sodium bisulfite, pH 7.0, containing 10 mM MgClg, to a 
final concentration of 30 Agigg/mL. Controls samples were dissolved in 10 
mM Tris-HCl, pH 7.0, with 10 mM MgCl2. The samples were incubated at room 
temperature (27°C) for 4 h. After addition of two volumes of H2O, the 
tRNA solutions were dialyzed twice against 500 mL of 0.15M NaCl in 20 mM 
sodium acetate, pH 4.5, for a total of 16 h. The RNA was then precipi­
tated by addition of two volumes of ethanol and prepared for ^^F NMR in 
the usual manner. 
Photoreaction of psoralen with FUra-containing tRNA 
Thirty mL samples containing equimolar concentrations of 4'-hydroxy-
methyl-4,5',8-trimethyl psoralen (HMT) (20 wg/mL) and FUra-substituted 
tRNA (200 ug/mL) in 10 mM Tris-HCl, pH 7.4, and 0.1 mM EDTA were placed in 
Pyrex glass tubes. Samples were deoxygenated by flushing with nitrogen 
for 1 h, and irradiated at 365 nm for 5 min in a Rayonet photoreactor 
equipped with RUL 3500-A lamps. The temperature of the sample was ca. 5°C 
After irradiation, the samples were extracted twice with two volumes of 
chloroform/isoamyl alcohol (24:1, v/v), three times with ether, and then 
ethanol precipitated three times to remove unbound HMT. 
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Oligonucleotide synthesis 
GpUpA and GpUpApA were synthesized from GpU as primer and ADP with 
polynucleotide phosphorylase {Miorooooous luteua), by the procedure of 
Thach and Doty (1965). The reaction, shown below, 
GpU + nADP < > GpU(pA)n + nPi 
is reversible, resulting in phosphorolysis of the ribooligonucleotides. 
The chain length distribution of oligonucleotides synthesized is, there­
fore, determined by the ratio of nucleotide-5'-diphosphate to primer orig­
inally present in the reaction mixture, provided that the mixture is incu­
bated long enough to reach equilibrium. The conditions used to obtain 
optimal synthesis of tri- and tetranucleotides were 7.5 mM primer, 20 mM 
ADP, 10 mM MgCl2, 0.4 M NaCl, 0.2 M Tris-HCl pH 9.3 and 1.2 mg/ml poly­
nucleotide phosphorylase. After the reaction mixture had been incubated 
for 90 h at 34°C, the sample was heated to 90°C for 15 min to inactivate 
the enzyme. The volume of the mixture was increased two fold by addition 
of H2O, and bacterial alkaline phosphatase (18 ng/mL) was added to hydro-
lyze any unreacted ADP. CpGpApA was synthesized in the same manner using 
CpG as primer. 
The resulting oligonucleotides were separated on a DEAE-cellulose 
column (1.5 x 15 cm) using a 2 x 400 mL linear gradient containing 5-
500 mM triethylammonium bicarbonate (TEAB) pH 8.0. An example of the 
elution profile obtained for GpU(pA)n synthesis is shown in Figure 4. 
Each successive peak represents an oligonucleotide containing one more 
adenylate residue than the preceding one. The tri- and tetranucleotides 
were further purified on a DEAE-Sephadex A-25 column (0.9 x 20 cm), using 
a 2 X 100 ml linear gradient containing either 0.05-0.5 M or 0.1-1.0 M 
TEAB. Fractions containing the desired products were evaporated to 
dryness, and triethyl ammonium bicarbonate was removed by repeated addition 
of 50% methanol and evaporation. In the final step, the oligonucleotides 
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Figure 4. DEAE-cellulose ion exchange chromatographic separation of products from the poly­
nucleotide phosphorylase reaction of G-U with ADP. The column was eluted at room 
temperature with a linear gradient of 5 to 500 mM triethyl ammonium bicarbonate 
(TEAB), pH 8.0, at a flow rate of 1.0 mL/min 
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were converted to the ammonium salt by passage over Dowex SOW-XSfNH^*) and 
then lyophilized to dryness. Yields were 26% for GpUpA, and 12% for both 
GpUpApA and CpGpApA, based on the dinucleoside monophosphate primer. 
ApUpG was prepared by a ribonuclease Tj assisted, polynucleotide 
phosphorylase catalyzed addition of GDP to ApU (Mohr and Thatch, 1969). 
Reaction conditions were 7 mM primer, 35 mM GDP, 0.2 M Tris-HCl, pH 8.3, 
10 mM MgClg, 0.5 mg/mL polynucleotide phosphorylase, and 300 units/mL of 
ribonuclease Tj. The reaction was incubated 24 h at 34°C and the products 
were purified as described above. The yield of ApUpG was 76%. 
The tetranucleotide GpUpApG was prepared by elongating GpUpA with GDP 
using polynucleotide phosphorylase, as described by Uhlenbeck et al. 
(1970). Reaction conditions were those described for GpUpA synthesis 
except that the concentration of GpUpA as primer was 1.0 mM, GDP was 
0.5 mM, and the enzyme concentration was 0.3 mg/mL. The reaction was 
incubated for 2 h at 34°C before being heat inactivated and dephosphory-
lated as described above. Twenty-four percent of the GDP was incorporated 
into the tetramer. 
The syntheses of GpUpApC and GpUpApU were accomplished by using T4 
RNA ligase to join GpUpA to the 3',5'-nucleoside bisphosphates pCp and 
pUp, respectively (England and Uhlenbeck, 1978). RNA ligase reactions 
were carried out in 1.0 mL containing 0.17-0.30 mM nucleoside bisphosphate 
as donor, 0.7-1.2 mM GpUpA as acceptor, 0.5 mM ATP, 20 mM MgClg, 50 mM 
HEPES, pH 8.3, 10 ng/mL bovine serum albumin, 3.3 mM dithiothreitol, and 
50-150 units/mL T4 RNA ligase. Reactions were incubated at 37°C for 4 h 
and then heated to 90°C for 2 min to inactivate the ligase. After dilu­
ting the sample two-fold with water, 150 pig/mL of bacterial alkaline phos­
phatase was added to hydrolyze the phosphate from the 3' end of the tetra-
nucleotides. The tetranucleotide products were separated from unreacted 
trimer by chromatography on DEAE-cellulose as described for the purifica­
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tion of GpUpA, except that the TEAB gradient was 50-400 mM. Yields were 
31% for SpUpApC and 21% for GpUpApU. 
The nucleoside composition of all the synthetic oligonucleotides used 
in these studies was confirmed by the tritium derivative method of 
Randerath et al. (1980) (scaled down version 2). The results of these 
analyses are shown in Table 1. In each case the composition of the 
purified oligonucleotide was within experimental error of that expected. 
Table 1. Analysis of Synthetic Oligonucleotides 
Nucleoside Ratios 
Oligonucleotide Guanosine Uracil Adenosine Cytosine 
GpUpA 1.00® l.OSiO.Ogb 0.97±0.12 0.01±0.00 
GpUpApA 1.00 0.95±0.08 1.88±0.08 0.00±0.02 
GpUpApC 1.00 1.28±0.02 1.04±0.01 1.16±0.06 
GpUpApG 1.89±0.08 1.00 1.04±0.03 0.02±0.01 
GpUpApU 1.00 2.22±0.016 1.10±0.08 0.05±0.01 
CpGpApA 1.00 0.07±0.01 2.04±0.12 0.90±0.04 
^Results are normalized to the value shown as 1.00. 
^Standard deviation in duplicate analyses. 
NMR spectroscopy 
For NMR spectroscopy, transfer RNA samples (2.5-5.5 mg) were 
dissolved in a minimum volume of the buffer to be used in each experiment, 
and were then dialyzed against two changes of at least 1000 volumes of the 
same buffer, using a flow dialysis microcell (BRL model #1200 MA). After 
dialysis, the volume of the sample was adjusted to 0.3 mL, and 10% (v/v) 
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2^20 was added to serve as an internal lock signal. Standard conditions 
are 50 mM sodium cacodylate, pH 6.0, 15 mM MgCl2* 100 mM NaCl, and 1 mM 
EDTA. The sample was then transferred to a Wilmad 529A-10 NMR microtube, 
which was suspended in a 10 m NMR sample tube and surrounded with sample 
buffer containing 1 mM 5-fluorouracil as an external standard. 
For studies at low divalent cation concentration, Mg** was removed 
from the tRNA by dissolving it in 20 mL of 10 mM EDTA, pH 7.0, heating to 
70°C for 5 min, and allowing the sample to cool slowly to room tempera­
ture. The tRNA was then precipitated with ethanol, collected, dissolved 
in sample buffer that had been treated with Chelex 100, and then dialyzed 
against this buffer, as described above. Transfer RNA treated in this 
manner contained less than 0.1 mol of Mg** per mol of tRNA, as determined 
by atomic absorption measurements on a Perkin-Elmer 2000 AA spectrometer 
(kindly provided by Dr. E. Travis Littledike, National Animal Disease 
Center, Ames Iowa). 
Magnesium, manganese, sodium, or spermine was added as small aliquots 
of a concentrated stock solution prepared in the same buffer as the tRNA 
solution. Oligonucleotides were added as lyophilized solids. 
NMR spectra were obtained at room temperature (unless otherwise 
noted) on a Bruker WM300 pulsed FT NMR spectrometer at 282 MHz. Spectra 
were collected by using 8K data points, with no relaxation delay and a 37° 
pulse to optimize the Ernst condition (Shaw, 1976), except when making 
area measurements, in which case a 5 sec relaxation delay and 90® pulse 
angle were used to ensure complete relaxation. Typically 10,000 to 30,000 
scans were collected and 10 Hz spectral line broadening was used. Chemi­
cal shifts are reported relative to free 5-fluorouracil; shifts to higher 
shielding are indicated by negative numbers. Integration of peak areas 
was accomplished using DISNMR software with an Aspect 2000 microcomputer. 
After each set of experiments, the activity of the tRNA was checked by 
47 
aminoacylation assay,and degradation was monitored by polyacrylamide gel 
electrophoresis. 
For NMR experiments, transfer RNA was dissolved in 0.3 mL of 30 mM 
sodium phosphate, pH 6.0, 20 mM MgCl2* 100 mM NaCl. The samples were then 
dialyzed against this same buffer in the manner described for NMR. 
Transfer RNA was transferred to by twice lyophilizing the sample to 
dryness and redissolving it in 99.996% ^H^O (Strohler Isotope Chemical). 
Oligonucleotides used for NMR were prepared as described previously, 
then dissolved in and lyophilized to dryness prior to use. NMR 
spectra were collected on a Bruker WM300 FT NMR as described previously 
for ^®F NMR except that 16K data points were used. Proton chemical shifts 
are reported relative to OSS. 
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RESULTS 
Purification and Partial Characterization of FUra-substituted tRNAjJ]®^ 
The results to be presented involve studies with three purified FUra-
substituted E. ooli transfer RNAs: tRNA, tRNA^®*, and tANA^^t, Previ­
ous publications describe the preparation and properties of the valine 
tRNA (Horowitz et al., 1974) and initiator methionine tRNA (Hills 
et al., 1983). Elongator methionine tRNA, tRNA^J®^, from FUra-treated 
cells was purified for the first time in the course of this research, and 
its preparation and some of its properties will be described. 
Purification of (FUra)tRNA^^^ 
A summary of the purification of FUra-substituted tRNA{J|®^, as 
described under methods, is shown in Table 2. During chromatography on 
BD-cellulose, (FUra)tRNA}J|®^ is resolved into two components (Fig. 5A), 
designated form A and B according to their order of elution. This behav­
ior is similar to that of (FUra)tRNAf®^, which is also resolved into two 
isoaccepting species on BD-cellulose (Hills et al., 1983). Purified 
(FUra)tRNAMGt form A had a specific activity of 1275 pmol/A26o and consti­
tuted 26% of the tRNA^^t recovered (Table 2), while form B, had a specific 
activity of 1500 pmol/A250 and made up 56% of the total (Table 2). (The 
remaining 18% of the (FUra)tRNA{JJ®^ was an unresolved mixture of the two 
forms). Both isoacceptors activity is comparable to that of normal 
tRNAjJj®^, indicating that despite the massive substitution by 5-fluoro-
uracil, this tRNA is fully capable of being aminoacylated. Neither isoac-
ceptor could be formylated (less than 1%), and both forms migrated as a 
single band on 15% polyacrylamide gels (results not shown). 
Reverse phase chromatography of (FUra)tRNA|jJ®^ on RPC-5 gave only 
slight additional purification (Table 2). However, a partial resolution 
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Table 2: Summary of purification of FUra-substituted tRNAjJj®^ 
tRNA 
(*260) 
sp act 
(pmol/A26o) 
total tRNAMet 
(pmoir Recovery % 
DEAE-cellulose 8030 150 1.20x10® (100) 
Sepharose 4B 1127 887 1.00x10® 83 
Sephadex A-50 722 1127 8.00x10® 66 
BD-cellulose (A) 152 1215 1.85x10® 15 
(B) 317 1492 4.73x10® 39 
RPC-5 (A) 107 1275 1.40x10® 12 
(B) 245 1544 3.80x10® 32 
of isoacceptor A into two peaks was noted (Fig. 5B). Isoacceptor B chro-
matographed as a single broad peak on RPC-5 (Fig. 5C) with some indication 
of heterogeneity. In both cases, the absorbance at 260 nm paralleled the 
methionine acceptance activity. Similar behavior was also noted for chro­
matography of (FUra)tRNA^^t on RPC-5; two peaks were obtained with form A, 
whereas form B chromatographed as a single peak (Hills et al., 1983). 
These results suggest the existence of additional forms of both FUra-
substituted methionine tRNAs, and other evidence indicates additional 
forms of FUra-substituted tRNAj®^ (Hardin, 1984). The nature of these 
additional forms, however, has not been Investigated. 
Nucleoside analysis of (FUra)tRNA^^^ 
The nucleoside composition of both forms of FUra-substituted tRNAjJJ®^, 
as determined by the tritium derivative method (Randerath et al., 1980), 
is shown in Table 3. As described previously for FUra-substituted valine 
tRNA (Horowitz et al., 1974) and initiator methionine tRNA (Hills et 
Figure 5. Chromatography of FUra-substituted tRNAjJI®^. 
(A) Separation of two forms (A and B) of (FUra)tRNAjJ}®^ on 
BD-cellulose. Transfer RNA recovered from DEAE-Sephadex 
chromatography (see flethods) was applied to a BD-cellulose 
column. The column was developed with a linear NaCI 
gradient from 0.4 to 1.0 M. Fractions of 2.0 ml were 
collected at 24 mL/h. 
(B) Chromatography of (FUra)tRNA{J}®^ form A on RPC-5. 
Isoacceptor A from BD-cellulose was applied to an RPC-5 
column and the column was then developed with a 0.5-1.0 M 
NaCl linear gradient. One mL fractions were collected at a 
flow rate of 1.4 mL/min. 
(C) RPC-5 chromatography of (FUra)tRNA^®^ form B. 
Isoacceptor B from BD-cellulose chromatography was 
chromatographed as described above for the A form, (o) 
Absorbance at 260 nm; (•) methionine acceptance activity; 
(A) NaCl concentration 
too iso 
Fraction Number 
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Table 3. Nucleoside composition of 5-fluorouracil-substituted tRNA{j^ Met 
Nucleoside Expected # of residues (A) Form (B) Form 
Guanosine 18 17.5 ± 0.23* 17.8 ± 0.22 
Cystosine 19 20.3 ± 0.03 20.1 ± 0.03 
Adenosine 18 17.8 ± 0.06 18.1 ± 0.20 
Uracil 9+lb 0.48 ± 0.03 0.47 ± 0.02 
5-Fluorouracil 18(17)C 15.8 ± 0.09 16.8 ± 0.05 
5-Fluorocytosine 0 0.61 ± 0.03 0.76 ± 0 
Ribothymidine 1 - -
Pseudouracil 1 - -
Dihydrouracil 1 - -
m/Guanosined 1 0.98 ± 0.05 0.92 ± 0.08 
t^Adenosine 1 0.13 ± 0.01 0.17 ± 0.02 
2'OmGuanosine 1 _e _e 
ac^Cytosine 1 J 
x* 1 J _f 
s^uracilG 1 _9 _9 
^Standard deviation in duplicate analyses. 
^s^uracil is converted to uracil during labeling procedure. 
^18 residues (B) form, 17 residues (A) form (see text). 
^Corrected for 64% recovery. 
®Can't be determined by the ^H-labeling method (Randerath et al., 
1980). 
^Not determined. 
9X is 3N-(3-amino-3-carboxypropyl) uracil. 
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al., 1983), nearly all the uracil and uracil-derived modified nucleosides 
of (FUra)tRNAM^t replaced by 5-fluorouracil (Table 3). More than 95% 
of the uridine is replaced by FUra, and the residual levels of dihydrouri-
dine, pseudouridine, and ribothymidine are virtually undetectable. Values 
obtained for the other major nucleosides (adenosine, guanosine, and cyto-
sine) are all very close to the number of residues expected (Table 3 and 
Figure 2), although the value for cytosine is slightly high. Approxi­
mately 35» of the cytosine in (FUra)tRNA^®^ is replaced by 5-fluorocyti-
dine. Similar levels of 5-fluorocytidine were also noted in FUra-substi­
tuted tRNAj®^ (Horowitz et al., 1974) and (FUra)tRNAf®^ (Hills et al., 
1983). The nonuridine-derived modified nucleoside t^A was present at less 
than 20% of the normal level. 
The only significant difference in the nucleoside composition of the 
two isoacceptors of (FUra)tRNA}Jj®^ is that form B contains one more FUra 
than form A. Previously, it was shown that the two isoaccepting forms of 
FUra-substituted initiator methionine tRNA differ only in that form A 
contains a modified 5-fluoro-5,6-dihydrouridine at position 20 (normally 
occupied by dihydrouridine), whereas form B contains 5-fluorouridine at 
this position (Hills et al., 1983). Fluorodihydrouridine is extremely 
alkali-labile and undergoes a ring-opening reaction to yield fluoroureido-
propionic acid during chromatography on DEAE-cellulose (at pH 8.9) [used 
to separate normal from FUra-substituted tRNA] (Horowitz et al., 1983). 
Therefore, the A form of (FUra)tRNAf®^ contains one less FUrd residue than 
form B (Hills et al., 1983). The results in Table 3 suggest that a 
similar situation exists with FUra-substituted tRNAjj]®^. 
^^F NMR spectra of FUra-substituted tRNA^^t 
^®F NMR spectra of both isoacceptors of 5-fluorouracil-substituted 
tRNA^bt, recorded at pH 6.0 in 15 mM MgClg and 100 mM NaCl at room temper-
Figure 6. NMR spectra of 5-fluorouracil-substituted tRNAjJI®^. (A) 
Isoacceptor A (0.50 mM). (B) Isoacceptor B (0.60 mM). The 
tRNA samples were dissolved in standard buffer (see 
Methods) and the spectra were recorded at 25°C. Areas of 
each region of the spectrum were obtained by integration on 
the spectrometer and were normalized to the area of peak D. 
Peak designations are also indicated 
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ature, are shown in Figure 6. Thirteen resolved resonances and two 
shoulders are visible in the spectrum of form B, corresponding to the 18 
FUra residues in the analogue substituted tRNA (see cloverleaf insert in 
Fig. 6). Relative areas of each region of the spectrum, obtained by 
integration on the spectrometer and normalized to the area of peak D, are 
also indicated. Due to the large number of peaks and the degree to which 
many of them overlap, the exact location of all the ^^F signals in this 
spectrum is difficult to determine, and some questions remain regarding 
the exact number of resonances in the region between 5 and 7 ppm, and 
between 1.5 and 2.5 ppm. 
The ^®F spectrum of the A form of FUra-substituted tRNA^et differs 
from that of the B form mainly by the shift of one resonance from 4.6 ppm 
(peak F) in isoacceptor B to -15 ppm in isoacceptor A (Fig. 6). As 
described previously, similar differences exist between the ^®F NMR 
spectra of the A and B forms of FUra-substituted tRNA^®^ and of (Fig. 3B) 
(FUra)tRNAj®^ (3A). The ^®F signal at -15 ppm has been shown to be due to 
a ring-opened fluorodfhydrouridine substituent in the A form of FUra-
substituted tRNA (Horowitz et al., 1983). The difference between the ^®F 
spectra of the two isoacceptors of (FUra)tRNA{J}®^ is also likely due to the 
presence of a modified fluorodihydrouridine. The position of this modi­
fied FUra will be discussed in the next section. 
A comparison of the ^®F NMR spectrum of (FUra)tRNA{J|®^ (Fig. 6) with 
the previously obtained spectra of FUra-substituted tRNA][®^ (Fig. 3A) and 
tRNAf®^ (Fig. 3B) shows that there are similarities among all three, as 
well as some unique features in the tRNAjjj®^ spectrum. Although the range 
of chemical shifts for the ^®F resonances is similar in all three spectra 
(ca. 0.5 to 8.0 ppm downfield from FUra), the ^^F spectrum of 
(FUra)tRNAMGt contains a resonance farther upfield, at 0.3 ppm, than any 
resonance in the other two spectra. The spectrum of (FUra)tRNA}[|®^ also 
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contains at least four resonances in the downfield portion of the spectrum 
(5.5-8.0 ppm) whereas spectra of fluorinated tRNA][®^ and tRNA^^ show only 
three peaks In this area. 
Determination of the position of f1uorodihydrouridine in (FUra)tRNA 
The modified fluorodihyrouridine in (FUra)tRNA^®^ has been located at 
position 20 in isoacceptor A by sequence analysis of both forms of this 
analogue-substituted tRNA (Hills et al., 1983). However, the location of 
the modified FUra in (FUra)tRNA-[®^ and (FUra)tRNA}Jj®^ has not been deter­
mined. To determine the position of the modified FUra in the A form of 
these tRNAs, both isoacceptors of each tRNA, labeled at their 5' ends with 
32p (see Methods), were treated with aniline buffered at pH 4.5. Modifi­
cation of 5-fluorourac11 to fluorodihydrouracil and the subsequent alkali-
catalyzed ring-opening of the modified base (during chromatography on 
DEAE-cellulose at pH 8.9) renders the tRNA susceptible to aniline induced 
strand scission at the position of this residue. The cleavage products 
were then analyzed by polyacrylamide gel electrophoresis. Both forms of 
(FUra)tRNA^Gt were also analyzed by this method. 
Positions of aniline cleavage were determined by comparing the 
cleavage sites to a partial ribonuclease T1 digest ladder. The mobility 
of bands corresponding to RNase T1 fragments do not coincide exactly with 
those produced by aniline cleavage because oligonucleotides produced by 
RNase T1 terminate in a 3'-phosphate, whereas fragments generated by 
aniline cleavage terminate in an aniline-substituted 3'-r1bose (Maxam, 
1983). As a result, the aniline cleavage fragments are retarded by 
approximately one nucleotide Interval relative to the corresponding RNase 
T1 fragments. 
As shown in Figure 7, the major cleavage site observed in the A form 
of each tRNA that is not present indicates the position of the fluorodi-
Figure 7. Localization of 5-fluorodihydrouridine in FUra-substituted tRNAs. Autoradiograms 
of 15% sequencing gel analysis of fragments derived by aniline (pH 4.5) cleavage 
of the A and B forms of 5' ^^P-labeled 5-fluorouracil-substituted tRNA^®^, 
tRNAj®^, and tRNA^^®^. Control samples were incubated in 50 mM sodium acetate, 
pH 4.5. All incubations were at 50°C for 20 min. A ribonuclease T1 sequencing 
ladder (see Methods) was used to identify the sites of cleavage 
(FUra) tRNA*!®* (FUra) tRNA' (FUra)tRNA^ 
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hydrourldine residue. In (FUra)tRNA^®*, the site of the modified FUra is 
located at position 20, confirming previous findings (Hills et a1.« 1983). 
The fluordihydrouridine is located at position 17 in (FUra)tRNA][®^ and at 
position 20 in (FUra)tRNA}J}®^ (Fig. 7). [A second minor band, with mobil­
ity slightly faster than the major band, is also observed in the A form of 
each tRNA, possibly due to a partial loss of the aniline moiety from the 
3' end of the fragment (Maxam, 1983)]. Aniline also cleaved both forms of 
the methionine tRNAs at m/G-47. 
The modified fluorodihydrouridine in the A form of each tRNA is 
located in the D loop (Fig. 2) at a position normally occupied by 5,6-
dihydrouridine. The D loop of tRNAjJ}®^ normally contains 3-4 dihydro-
uracils (Cory and Marcker, 1970). All of these sites are replaced by 
fluoropyrimidines (Table 3), but only the FUra at position 20 in the A-
form is reduced to fluorodihydrouracil. 
^^F NMR Studies of the Solution Structure of FUra-substituted tRNA 
To understand the function of tRNA, knowledge of the dynamic struc­
ture of the molecule in solution is essential. Using ^®F NMR effectively 
as a probe of tRNA conformation requires an understanding of the environ­
mental factors which influence the spectra of FUra-substituted tRNAs. 
These studies were undertaken to characterize the effect of pH, ionic 
environment, temperature, and chemical modification on the spectra. 
Specific assignment of the ^^F signals in the spectra to individual FUra 
residues in the tRNA molecule is necessary before spectral changes can be 
interpreted at the molecular level, and these experiments represent an 
initial approach to the assignment problem. 
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Effect of £H on the NMR spectrum of FUra-substituted tRNA 
Ionization produces large downfield shifts of the NMR resonance 
of 5-fluorouracil. Dissociation of the N(3) proton of 5-fluorouridine 
shifts the signal over 1.6 ppm downfield (Hardin, 1984), and Alderfer 
et al., (1983) have reported a downfield shift of nearly 2.7 ppm as a 
result of the ionization of poly(FU). 
Figure 8A shows the effect of changing pH on the ^^F NMR spectrum of 
FUra-substituted tRNA^®^, and the pH dependence of the chemical shift of 
each peak is shown in Figure 8B. Changing the pH from 4.5 to 8.75 
produces differential effects on the chemical shifts of the various peaks 
in the spectrum. The most pronounced effect of increasing pH is on ^®F 
resonances in the central portion of the spectrum (3.8 to 5.5 ppm). These 
peaks shift downfield 1.0-2.5 ppm over the pH range of 6.0 to 8.75. This 
behavior is similar to that of 5-fluorouridine (Hardin, 1984) and indi­
cates that these residues have pKas close to that of free FUrd. One reso­
nance in this region, labeled peak G, is unaffected by changing pH from 
4.5 to 8.75. 
The ^^F resonances in the upfield portion of the spectrum (above 3.8 
ppm) are largely unperturbed by changes in pH, indicating that the N(3) 
proton of these FUra residues has not dissociated even at pH 8.75. The 
farthest downfield resonances (peaks A and B) also do not change chemical 
shift significantly between pH 4.0 and 8.75. 
Some interesting changes in the spectrum occur at low pH. As the pH 
is raised from 4.5 to 6.0, peak C shifts downfield and peak F moves 
upfield. These effects may reflect conformational changes in the tRNA 
rather than dissociation of the N(3) proton, especially in the case of 
peak F, which shifts upfield with increasing pH, because this movement is 
the opposite of that seen with dissociation of N(3)-H. Because 5-fluoro­
uridine has a pKa of 7.57 (Wempen et al., 1961), ^®F NMR spectra of FUra-
Figure 8. Effect of pH on (FUra)tRNA][®^. 
(A) NMR spectra of (FUra)tRNAj®^ at various pHs. 
The tRNA (0.22-0.40 mM) was dialyzed against buffers of the 
indicated pH values. Buffers used were 50 mM sodium caco-
dylate containing 100 mM NaCl and 15 mM MgCl2 (pH 4.5-7.50) 
and 5 mM Tris-HCl containing 150 mM NaCl and 15 mM MgCl2 
(pH 8.0-8.75). Both buffers also contained 1 mM EDTA, and 
10% ^HgO as an internal lock. 
(B) The pH dependence of the chemical shifts of ^®F 
resonances identified in (A) 
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substituted tRNA were usually recorded at pH 6.0 to minimize effects due 
to ionization of the incorporated FUra. 
NMR studies of ion binding to FUra-substituted tRNA 
The conformation of transfer RNA is sensitive to the concentration of 
cations such as magnesium and sodium, which serve to stabilize the folded 
three-dimensional structure of this negatively charged polynucleotide (for 
review see Schimmel and Redfield, 1980). In addition, spermine and magne­
sium affect many of the biological activities of tRNA, including amino-
acylation (Loftfield et al., 1981) and protein synthesis (Thompson et al., 
1981). Changing the concentration of cations also affects the ^®F NMR 
spectra of FUra-substituted tRNAs. Characterization of these effects may 
aid in making peak assignments in the spectra, and eventually these 
studies may yield valuable information regarding the conformational states 
of tRNA in solution. 
Magnesium ions As shown in Figure 9A, magnesium has a large 
effect on the ^^F NMR spectrum of FUra-substituted tRNA^®^. The tRNA 
sample used to obtain the spectrum labeled 0 Mg"*"*" contained less than 0.1 
Mg**/tRNA as determined by atomic absorbtion spectroscopy. By titrating 
the tRNA solution with added Mg** it is possible, in most cases, to iden­
tify which resonances in the absence of magnesium correspond to signals in 
the presence of Mg**. These peaks are labeled in Figure 9A, and Figure 9B 
shows the affect of Mg** on the chemical shift of the individual reso­
nances in the spectrum. In some cases, ambiguities arise due to peaks 
overlapping. In these situations, it was generally assumed that trends in 
shift patterns are continuous. Also, in some instances the properties of 
certain ^®F resonances, such as shifts induced by codon binding (see later 
Results), were used to aid in making peak identifications. 
Most of the ^®F peaks shift downfield as the concentration of magne­
sium is increased. The largest effect occurs with peak A, which moves 
Figure 9. Effects of magnesium on (FUra)tRNA][®^. 
(A) NMR spectrum of (FUra)tRNA2®^ at various levels of 
magnesium. Magnesium was removed from the tRNA 
(<0.1 Mg**/tRNA) as described under Methods, and the tRNA 
sample (0.44 mM) was dissolved in standard buffer lacking 
Mg"*^. MgCl2 was then added to give the indicated molar 
ratios of Mg**/tRNA. 
(B) Magnesium ion dependence of the chemical shifts of ^®F 
resonances identified in (A). D indicates peak positions when 
the sample is dialyzed against buffer containing 15 mM MgCl2 
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over 3 ppm downfield as the Mg** ratio is increased from 0 to 50/tRNA. 
This resonance is also the most sensitive to changes in the NaCI concen­
tration (Fig. 10). Peaks J and K also exhibit large shifts (over 1 ppm) 
in this range of Mg**. These shifts all start at the lowest magnesium 
level, but the changes reach completion at different levels of Mg**. Peak 
A shifts in a continuous manner over the entire range of [Mg**], and the 
process does not appear to be complete by 50 Mg**/tRNA. The downfield 
movement of peak K is completed by 40 Mg**/tRNA, whereas peak J stops 
shifting by 20 Mg++/tRNA. 
Two resonances in the central portion of the spectrum, peaks G and H, 
also shift 0.2 and 0.5 ppm downfield, respectively, as the Mg**/tRNA ratio 
is raised from 0 to 20; no further shifts are observed for these peaks 
with increasing Mg**. Peak F demonstrates an unusual behavior. This 
resonance remains at 3.8 ppm until the Mg** level is raised above 30/tRNA; 
it then shifts downfield to 4.3 ppm as the Mg** concentration is 
increased. The movements of peaks F, G, and H are difficult to follow in 
the central portion of the spectrum because all three overlap when the 
magnesium concentration is between 20 and 30/tRNA. Peaks F and H could, 
however, be identified on the basis of their behavior on binding of tri-
and tetranucleotide codons to (FUra)tRNA^®^ (see Fig. 28). These reso­
nances are also the most temperature sensitive peaks in the spectrum in 
the absence or presence of magnesium (see Figure 16; also Hardin, 1984). 
Addition of 50 Mg**/tRNA restores the ^^F NMR spectrum of 
(FUra)tRNAj®^ to that observed when the sample is dialyzed against 15 mM 
MgClg (compare Fig. 9A with 3B; also see Fig. 9B). The only exception is 
peak A which is found farther downfield in the dialyzed sample. This 
result indicates that the effects of Mg** removal are reversible. 
The results obtained upon addition of Mg"*"*" to (FUra)tRNA][®^ (Fig. 9) 
were, in general, similar to those obtained previously by Hardin (1984). 
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However, improved resolution in the NMR spectra has allowed new interpre­
tation of the current data. 
Sodium ions The effect of sodium concentration, in the presence 
of 15 mM Mg**, on the NMR spectra of FUra-substituted tRNA^®^, 
tRNA^®^, and tRNA^Gt shown in Figure 10, and the dependence of the ^^F 
chemical shifts for each resonance from all three tRNAs is plotted in 
Figure 11. In each case, the farthest downfield peak at low ionic 
strength (peak A) shifts upfield dramatically (over 2 ppm) as the NaCl 
concentration is raised from 0 to 500 mM. This behavior may indicate that 
the downfield resonance in each spectrum corresponds to a residue in a 
conserved structural feature of these three tRNAs. A second resonance, in 
the central portion of each spectrum, also shifts upfield approximately 
0.8 ppm as the [NaCl] is increased. These peaks are labeled F, G, and I 
in the spectra of FUra-substituted tRNA^^l, tRNA^®^, and tRNA}J|®^, respec­
tively, and may also be derived from FUra residues in a conserved feature • 
of the three tRNAs (see Discussion). 
In (FUraitRNAi^l, two additional ^®F resonances also shift slightly 
upfield with increasing ionic strength: peak K, originally at 2.8 ppm, and 
peak N, the farthest upfield resonance. The remaining ^^F resonances in 
all three spectra are fairly insensitive to changes in the concentration 
of NaCl. The results obtained with (FUra)tRNA][®^ are similar to those 
described previously by Hardin (1984); however, improved resolution of the 
^^F NMR spectra has allowed new interpretation of the affects on peaks F 
and K. 
Physical studies of transfer RNA have shown that at ionic strengths 
greater than O.IM and moderate temperature (< 30°C), tRNA occurs in a 
"native" form even in the absence of magnesium (for review see Crothers 
and Cole, 1978). Gorenstein and Goldfield (1982) have shown that in 0.2 M 
Na"*" at 25°C, the NMR spectra of several tRNAs are quite similar in the 
tRNA^^' irna"5®* J IRNA Met 
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Figure 10. Effects of NaCl on the ^^F NMR spectra of FUra-substituted tRNA in the presence 
of magnesium (15 mM MgCTg). tRNA^a? (0.44 mM), tRNA^®^ (0.40 mM), or tRNAj]®* 
(0.34 mM) were dissolved in standard buffer (see Methods) containing the 
indicated NaCl concentrations 
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absence or presence of 10 mM Mg**, indicating that under these conditions 
the structure of the phosphodiester backbone of the tRNA remains largely 
unchanged even upon removal of Mg**. However, some differences were noted 
between the low and high Mg** spectra. These differences led the authors 
to suggest that at 19°C, 64% of the structure remains native while at 
39°C, only 21% of the native structure is present in the absence of magne­
sium (Gorenstein and Goldfield, 1982). 
The effects of Na"*" on the NMR spectrum of (FUra)tRNA][®^ at 24°C 
and in the absence of Mg** are shown in Figure 12. As the NaCl concentra­
tion is decreased, the downfield resonances, peaks B and C, are the most 
affected. Peak B splits into two components when the [NaCl] is below 150 
mM and eventually splits into three broad peaks with diminished intensity 
when the ionic strength falls below 35 mM NaCl. Peak C shifts upfield 
into the central cluster of peaks as the salt concentration drops. The 
upfield group of signals (0.5-2.5 ppm) also appears to decrease in inten­
sity while the intensity of the resonances in the central region of the 
spectrum increases as the ionic strength is reduced. These results resem­
ble those observed on thermal denaturation of (FUra)tRNA][®^ at 100 mM 
NaCl, in the absence of Mg** (Hardin, 1984), and likely represent unfold­
ing of the tRNA molecule at low ionic strength. 
Even at NaCl concentrations of up to 0.4M, the spectrum is not the 
same as that observed in the presence of 15 mM MgCl2 (compare Fig. 12 with 
3A). This result indicates that Na"*" cannot completely replace Mg** in 
determining the solution structure of transfer RNA. 
Manganese ions Manganese can substitute for magnesium, both in 
terms of the structure and functions of tRNA (Hyafil and Blanquet, 1977). 
The paramagnetic Mn** ion has been used in a number of NMR studies to 
probe divalent metal binding sites in tRNA molecules in solution (Chao and 
Kearns, 1977; Hurd et al., 1979; Gorenstein and Goldfield, 1982). The 
Figure 12. Effects of NaCl on the NMR spectrum of (FUra)tRNA-[®^ in 
the absence of Mg**. The tRNA (0.40 mM) was dissolved in 50 
mM sodium cacodylate buffer, pH 6.0, containing the indicated 
NaCl concentrations (mM) 
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large magnetic moment of Mn**, due to the unpaired electron, affects the 
relaxation times of nearby nuclei, resulting in broadening of the NMR 
resonances from these nuclei. The extent of broadening is determined both 
by the distance between the bound manganese ion and the nucleus, and the 
residence time of the manganese at the binding site (Eisinger et al., 
1965). Sites of Mn** binding in tRNA have been identified in the crystal 
structure of tRNA^^® (Jack et al., 1977). Determination of which reso­
nances in the NMR spectrum are perturbed by Mn**, may aid in assigning 
these peaks to FUra bases near these binding sites. 
The effect of manganese on the ^^F NMR spectrum of FUra-substituted 
tRNAi*! is presented in Figure 13. Selective paramagnetic line broadening 
effects are observed for peaks A, B, J, L, and N on addition of up to 0.04 
Mn** per tRNA-[®^ molecule, in the presence of 15 mM Mg"*"*", 0.1 M NaCl, 50 
mM sodium cacodylate, pH 6.0, and no EDTA. The largest effects occur with 
peaks J, L, and N. Broadening of these signals is detectable by 0.001 
Mn^^/tRNAi^T, and is quite severe when the ratio of Mn** to tRNA reaches 
0.04. Lesser effects are observed for peaks A and B, which begin to 
broaden when 0.007 Mn**/tRNA have been added. The remaining ^®F peaks in 
the spectrum of (FUra)tRNA-[®^ show little effect up to 0.04 Mn**/tRNA. 
It is interesting that two of the ^^F signals that are broadened by 
Mnpeaks A and J, are also highly sensitive to the concentration of 
magnesium (see Fig. 9), whereas the remaining three Mn** sensitive peaks 
are among the least affected by Mg**. The level of Mn** required to 
broaden specific ^^F resonances is very low. Broadening of some peaks can 
be detected when the tRNA to manganese ratio is 1000 to one, and the 
magnesium to manganese ratio is over 20,000 to one. 
Spermine The interaction of spermine with (FUra)tRNA][®^ was also 
examined. This polyamine can replace magnesium, at least partially, in 
stimulating the biological activity of tRNA in vitro (Igavashi and Takeda, 
Figure 13. Effects of manganese on the NMR spectrum of 
(FUra)tRNAj®^. The tRNA sample (0.55 mM) was dissolved in 
50 mM sodium cacodylate buffer, pH 6.0, 15 mM MgCl2» 
mN NaC], with no EDTA. MnCT? was then added to give the 
indicated molar ratios of Mn /tRNA. (D) the difference 
spectrum obtained by subtracting the spectrum obtained 
with 0.2 Mn**/tRNA from that collected in the absence of 
Mn++ 
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0.005 
0.02 
1 
CHEMICAL SHIFT [ PPM FROM FUra] 
79 
1970; Cohen 1971). The polyamine-tRNA interaction is also of interest 
since polyamines have been found to be essential to grow crystals of tRNA 
used in x-ray diffraction studies (Ladner et al., 1972; Kim et al., 1974), 
and two specific spermine binding sites are found in the crystal structure 
of yeast tRNA^he, Determination of the effect of spermine binding on the 
NMR spectra of FUra-containing tRNA may aid in assigning the peaks 
from FUra residues near the sites of spermine binding. 
Addition of one to seven equivalents of spermine results in changes 
in the chemical shift position of three resonances. A, I, and G, in the 
^^F NMR spectrum of (FUra)tRNA^®^ (Fig. 14). Peak A shifts upfield with 
increasing amounts of spermine. This shift appears to be a nonspecific 
ion effect since similar behavior occurs with increasing [NaCl] (Fig. 10) 
or [NH4CI] (data not shown), or decreasing levels of magnesium (Fig. 9). 
The resonance originally at 3.6 ppm, peak I, also shifts upfield and 
merges with peak J upon addition of spermine. Although not affected by 
magnesium (Fig. 9) or Na"*" (Fig. 10) peak J does shift upfield when NH4CI 
was added to the tRNA solution (data not shown). The most interesting and 
most specific effect of spermine on the ^®F NMR spectrum of (FUra)tRNA][®^ 
is on a resonance originally at ca. 4.0 ppm, in the G/H region. As 
increasing amounts of spermine are added, one of the two ^®F resonances in 
this compound peak shifts progressively downfield and eventually merges 
with peaks in the D/E/F region. From these results alone, it is not 
obvious whether this spermine-sensitive ^^F signal is peak G or H; how­
ever, tetranucleotide codon (GpUpApA) binding studies have demonstrated 
that it is peak G that shifts downfield upon spermine addition (see Fig. 
29). Peak G shifts only slightly upon removal of magnesium from the tRNA 
and is completely insensitive to changes in NaCl or NH4CI concentration, 
indicating that the effect of spermine on this peak is specific. 
Figure 14. Effect of spermine on the NMR spectrum of 
(FUra)tRNAj®^. The tRNA (0.32 mM) was dissolved in 
standard buffer (see Methods) and spermine was added to 
give the indicated molar ratios of spermine/tRNA' 
0 
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Temperature dependence of the NMR spectrum of (FUra)tRNAj[^^ 
Previous studies of thermal denaturation of (FUra)tRNA][®^ in 100 mM 
NaCl without Mg** (Hardin, 1984) show that as the temperature is 
increased, the farthest downfield peaks, B and C (5.5-7.0 ppm), melt 
first, followed by the upfield peaks (0.5-2.5 ppm), which disappear as the 
temperature is increased above 70°C. Both groups of resonances shift to 
the central region of the spectrum, and at 80°C the spectrum collapses 
into one broad peak centered at 4.7 ppm. 
At temperatures below 50°C and in the presence of 15 mM MgCl2» 
several resonances shift downfield as the temperature is increased 
before there is any indication of disruption of the tertiary interactions 
in the tRNA. The temperature dependence of the ^^F NMR spectrum of 
(FUra)tRNAj®^ in 15 mM Mg** is shown in Figure 15. Peak H is the most 
temperature sensitive resonance. This peak shifts 0.45 ppm downfield 
between 17° and 47°C, ultimately shifting downfield of peak G at 47°C. A 
resonance in the region between 4.0 and 5.0 ppm (Peaks D-F) also moves 
downfield with increasing temperature, until at 47®C a well-resolved reso­
nance at 4.9 ppm appears that was not observed at lower temperatures. 
Although identifying which resonance in the D/E/F region shifts downfield 
as the temperature increases is difficult, it appears to be the peak 
labeled F since peaks D and E are clearly visible throughout this temper­
ature range and do not shift. Peak M, originally at 1.9 ppm, also shifts 
downfield as the temperature is increased, improving the resolution 
between peaks M and N at higher temperatures. 
The line widths of all the ^^F signals in the spectrum narrow with 
increasing temperature. This effect, coupled with the shifts described 
above, results in the spectrum obtained at 47°C having resolved ^^F peaks 
for all 14 fluorouracil residues incorporated in (FUra)tRNA][®^. 
The changes in the ^®F NMR spectrum of (FUra)tRNA2®^ in the presence 
Figure 15. Temperature dependence of the NMR spectrum of 
(FUra)tRNAi®^. The tRNA (0.38 mM) was dissolved in 
standard buffer (see Methods) and ^®F NMR spectra were 
recorded at the temperatures indicated (°C) 
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of magnesium occur below 50°C, well before melting of the tRNA, as judged 
by temperature-absorbance studies (Tm = 79°C) (Horowitz et al., 1974; 
Hardin, 1984). Therefore, these low-temperature changes likely represent 
a temperature-dependent conformational change in the tRNA structure prior 
to melting. 
Reaction of FUra-substituted tRNA][®^ with bisulfite 
Reaction of tRNA with sodium bisulfite at pH 7 provides a specific 
method for modification of uridine residues in single-stranded regions of 
the molecule (Furuichi et al., 1970). The product formed, 5,6-dihydrouri-
dine-6-sulfonate, is stable at pH 6, but incubation at pH 9 reverses the 
reaction. Under similar conditions, 5-fluorouracil also adds bisulfite 
across the 5,6 double bond, which leads to a large shift of the ^^F signal 
35-40 ppm upfield (Sander and Deyrup, 1972). Identification of the ^®F 
resonances affected by reaction with bisulfite could provide a method for 
identifying signals from FUra residues in single-stranded regions of the 
tRNA molecule. Previous studies of bisulfite modification of 
(FUra)tRNA2®^ (Hardin, 1984) showed that ^®F resonances in the central 
portion of the spectrum were affected. However, quantification and iden­
tification of the reactive residues were not possible in these experi­
ments. The current investigation was undertaken to determine the number 
and identity of resonances in the ^^F NMR spectrum of (FUra)tRNA2®^ that 
are affected by reaction with bisulfite. 
The ^®F NMR spectrum of bisulfite modified FUra-substituted tRNAj®^ 
is shown in Figure 16B. Formation of the bisulfite adduct results in the 
shift of four ^®F signals from the central portion of the spectrum (3.5-
4.5 ppm) upfield to a region 36-37 ppm upfield from free FUra. Comparison 
with a control spectrum (Fig. 16A), and examination of the differences 
between the spectra (Fig. 16C) permits identification of the four bisul-
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Figure 16. ^^F NMR spectrum of sodium bisulfite modified (FUra)tRNAÎ[^^. 
The reaction with sodium bisulfite was carried out as 
described in Methods. Spectra were recorded in standard 
buffer (see Methods). (A) ^^F NMR spectrum of unmodified 
(FUra)tRNAy®^ (0.17 mM); (B) spectrum of bisulfite modified 
(FUrajtRNA^Bl (0.17 mM); (C) difference spectrum obtained by 
subtracting (B) from (A) 
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fite reactive residues as those corresponding to peaks D, E, F, and H, 
indicating that these residues exist in loop regions of the tRNA. 
It is interesting to note that peak G, which is also located in the 
central portion of the spectrum, does not react with bisulfite under these 
conditions. Peak 6 is the only resonance in the central portion of the 
spectrum that is not pH titratable (Fig. 8); and measurement of the 
solvent isotope shift (SIS) on transferring the tRNA from H2O to also 
indicates that FUra G is not accessible to solvent (Hardin et al., 1986). 
Bisulfite modification also leads to a small upfield shift of peak I 
(Fig. 16B), resulting in peak I coalescing with peak J. The significance 
of this shift is not clear; it may represent a conformational change in 
the tRNA due to the chemical modification, or FUra I may be near one of 
the bisulfite modified FUra residues and experience a change in magnetic 
environment due to its proximity to the SOg adduct. 
Valine accepting activity of (FUra)tRNA][®^ was not affected by bisul­
fite modification. Both the modified and control sample retained more 
than 85% of their original activity (data not shown), indicating that 
bisulfite addition does not produce large conformational changes in the 
tRNA. Retention of activity in the bisulfite modified tRNA also suggests 
that the modified FUra residues are not involved in the recognition of 
this tRNA by valyl tRNA synthetase. 
Photoreaction of 4'-(hydroxymethyl)-4,5',8-trimethyl psoralen with FUra-
substituted tRNA][®^ 
Psoralens are a family of planar aromatic compounds that intercalate 
in base-paired regions of nucleic acids and can photoreact with the 5,6 
double bond of pyrimidines upon irradiation with long-wavelength (350 nm) 
ultraviolet light (for review see Cimino et al., 1985). Single-stranded 
nucleic acids also react, but to a lesser extent than helical structures 
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(Thompson et al., 1982). Bachellerie et al. (1981) have shown uridine is 
the most reactive base in RNA, and other studies indicate that 5-fluoro-
uracil is even more reactive than uracil (Harter et al., 1974; Ou and 
Song, 1978). Recently a number of psoralen derivatives, including 4'-
(hydroxymethyl)-4,5',8-trimethyl psoralen (HMT), have been developed which 
are more water soluble and more reactive than the parent compound (Isaacs 
et al., 1977). These derivatives have been used in a number of studies on 
RNA structure in solution (Bachellerie and Hearst, 1982; Thompson and 
Hearst, 1983; Neilsen and Leick, 1985). 
Photoaddition of psoralen to FUra residues in FUra-substituted tRNA 
should perturb the environment of the fluorine of the reacted bases, 
resulting in a change in the ^®F signal from these residues. This method 
could be used to identify ^®F resonances from FUras in double-stranded 
regions of the tRNA. Figure 17 shows the effects of photoreaction with 
HMT on the ^®F NMR spectrum of (FUra)tRNA2®^. The largest effects are 
seen in the upfield portion of the spectrum, between 2.0 and 3.5 ppm. 
Peaks I, J, and L show a decrease in intensity upon reaction with HMT 
(compare Fig. 17B with 17A). The furthest downfield resonance, peak A, is 
also reactive, whereas the peaks in the central portion of the spectrum do 
not appear to be affected. Two areas of the spectrum have increased 
signal intensity after reaction with HMT. These regions are located at 
4.7 ppm and at ca. 1.6 ppm. These increases may represent a shift of 
intensity from the signals which are diminished by HMT reaction. 
These results indicate that the ^^F signals in the upfield portion of 
the spectrum are derived from FUra residues in structural environments 
where HMT can intercalate and photoreact, presumably those located in 
base-paired regions of the tRNA molecule. 
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Figure 17. NMR spectrum of (FUra)tRNAj®^ after reaction with 
4'-hydroxymethyl-4,5',8-trimethylpsoralen (HMT). Reaction 
with HMT was performed as described under Methods. The 
spectra were recorded in standard buffer (see Methods). 
(A) ^^F NMR spectrum of (FUra)tRNA-[®^ (0.31 mM) irradiated at 
350 nm in the absence of HMT; (B) the spectrum of HMT modified 
(FUra)tRNA%al (0.31 mM) 
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NMR Study of Codon-Anticodon Interaction in FUra-Substituted tRNA 
The anticodon of FUra-substituted tRNA][®^ contains two FUra residues 
(Fig. 2); one at position 34 (the wobble position) normally occupied by 
uridine-5-oxyacetic acid, and a second at position 33, 5'-adjacent to the 
anticodon. Binding of complementary oligonucleotides to the anticodon 
loop is expected to perturb the ^®F signals from these FUra residues. To 
explore the structure of the anticodon loop and assign ^^F resonances in 
the spectrum of (FUra)tRNA^®^, interaction of this tRNA with oligonu­
cleotides complementary to the anticodon loop was investigated. 
Effect of codon-anticodon interaction on the ^®F NMR spectrum of 
(FUra)tRNAyaT 
Trinucleotide codons Figure 18 shows the ^^F NMR spectra of Fura-
substituted tRNA^*! recorded in the absence and presence of the codon 
GpUpA. The only significant change in the spectrum that occurs upon addi­
tion of increasing amounts of GpUpA is the progressive upfield shift of 
the ^^F resonance seen at 3.90 ppm in the absence of codon (Peak H, 
indicated by an asterisk). This behavior indicates that FUra H exists in 
two different magnetic environments, free and complexed with codon. The 
shift represents the weighted average of the two forms with rapid exchange 
between them, i.e., the rate of exchange is greater than irAu, where Au is 
the difference in chemical shift between the free and complexed state 
expressed in Hertz. In this case Au is 195 Hz (see below), which means 
the exchange rate is » 612 sec"^. 
Changes in the position of the peak with increasing concentrations of 
GpUpA are plotted in Figure 19A. Linear regression analysis of the double 
reciprocal plot of these data (Fig. 19B) indicates a maximum shift in the 
resonance position of this peak of 0.69 ppm (195 Hz) at infinite GpUpA 
concentration, which corresponds to the position of the peak when all the 
Figure 18. ^®F NMR spectra of FUra-substituted tRNAj®^ before (A) and 
after addition of 0.43 mM (B) and 2.23 mM (C) G-UpA. 
Solution conditions were 0.33 mM (FUra)tRNA][®^ in 50 mM 
sodium cacodylate buffer, pH 6.0, 100 mM NaCl, 15 mM 
MgClgt and 1 mM EDTA. Asterisks indicate peak H in each 
spectrum 
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Figure 19. Analysis of the binding of GpUpA to (FUra)tRNA][®^. (A) Plot of the change in 
chemical shift position, in ppm, of the resonance designated peak H at 
various concentrations of added G^U^A. Solution conditions were the same as 
iVal was 0.22 mM. (B) Double 
p p . 
Figure 18 except the concentration of (FUra)tRNAj[' 
reciprocal plot of the data in (A). (C) 
{FUra)tRNA][®^. The ratio of bound to free GLU-
fraction of the maximal upfield shift of peak H 
Scatchard plot of GpUpA binding to 
A was determined from the 
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tRNA is complexed with codon. Scatchard analysis of these data, shown in 
Figure 19C, was used to determine an association constant for the equilib-
(FUra)tRNA|[3U GUA ((FUra)tRNA][a^GUA ) 
The calculated binding constant, 2500 at 25°C and 0.1 M NaCl, agrees 
well with the value of 3000 for the association of GpUpA with normal 
tRNAj®^, determined by equilibrium dialysis at -2°C and at 1.0 M NaCl 
(Pongs and Griese, 1972). 
Addition of trinucleotides not complementary to the anticodon of 
tRNAi^l has no effect on the position of Peak H as shown in Figure 20 for 
the trinucleotide UpApA. Similar results obtained with ApApA and ApUpG 
(data not shown), indicate that the shift observed with GpUpA is codon 
specific and not due to nonspecific effects of added oligonucleotides. A 
preliminary assignment of the ^^F signal at 3.9 ppm (peak H) to FUra-34 in 
the anticodon of (FUra)tRNA2®^ can be made on the basis of the results of 
these trinucleotide codon binding experiments. 
Tetranucleotide codons The tetranucleotide GpUpApA is complemen­
tary to the anti codon of FUra-substituted tRNA][®^ and the 5'-adjacent 
FUra-33; it is expected to have a higher binding constant for the tRNA 
than GpUpA (Uhlenbeck, 1972). Addition of GpUpApA to (FUra)tRNAK®^ pro­
duces an upfield shift of the same ^^F resonance, at 3.90 ppm (peak H, 
indicated with an asterisk), which shifts when GpUpA is added (Fig. 21). 
With increasing GpUpApA concentration, the ^^F signal at 3.90 ppm dimin­
ishes in intensity while the area under the peak at 3.23 ppm (indicated by 
an arrow) increases (Fig. 21); no ^^F resonances are observed at interme­
diate positions. The position of the shifted peak is that expected from 
the maximal shift calculated with GpUpA (0.69 ppm), and at high GpUpApA 
concentrations intensity corresponding to approximately one FUra has 
shifted upfield. This behavior is evidence for a slow exchange 
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gure 20. NMR spectra of FUra-substituted tRNA}*! before (A) and 
after (B) addition of 1.95 mM UpApA. Solution conditions 
were those of figure 18 except the tRNA concentration was 
0.41 mM 
Figure 21. NMR spectra of FUra-substituted tRNA^®^ before (A) and 
after addition of 0.3 mM (B); 1.0 mM (C) and 1.8 mM (D) 
GpUpApA. The concentration of tRNA was 0.43 mM in 
standard buffer (see Methods). Arrow indicates shifted 
position of peak H 
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(« 612 sec'l) between the complexed and free forms of the fluorouracil 
residue; In contrast to the fast exchange observed with GpUpA. Such a 
difference Is consistent with greater stability of the complex between the 
tRNA and GpUpApA. Scatchard analysis, based on the relative Intensities 
of the two peaks corresponding to the resonance In the free and com­
plexed state, yields a binding constant of 6800 M"^, which agrees with 
values found by others for complementary tetranucleotides binding to the 
anticodons of several tRNAs. For example, Freier and Tinoco (1975) found 
a value of 6200 M"^ for ApUpGpA binding to yeast tRNA^he using equilibrium 
dialysis at 0°C and IM NaCl. The finding that GpUpApA binding to 
(FUra)tRNAj®^ also affects peak H supports the assignment of this ^®F 
resonance to FUra-34. 
In addition to the upfield shift of Peak H, binding of GpUpApA to 
FUra-substituted tRNA-[®^ induces the downfield shift of a peak originally 
at about 4.5 ppm, in the D/E/F region (Fig. 21). Increasing concentra­
tions of the tetranucleotide cause a progressively larger downfield shift 
of this resonance (Fig. 21). The affected resonance appears to be peak F, 
which is originally unresolved, because at high levels of GpUpApA the 
peaks labeled D and E are still visible at their original chemical shift 
positions. Addition of the tetranucleotide ApUpGpA, which is not comple­
mentary to the anticodon loop, causes no significant change in the ^®F NMR 
spectrum of (FUra)tRNAj®^ (data not shown). Based on the effects of 
GpUpApA binding on the ^®F spectrum of (FUra)tRNAi®^, a preliminary 
assignment of the resonance at 4.5 ppm (Peak F) to FUra-33 (5'-
adjacent to the anticodon) can be made. 
Characterization of the effect of the 3'-terminal A in GLUnA-A 
The 3'-terminal adenosine of GpUpApA may base-pair directly with 
FUra-33, and the downfield shift of the ^®F signal at 4.5 ppm (Fig. 21) 
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may be due to such an interaction. However, for FUra-33 to base-pair with 
GpUpApA, the anticodon loop would have to undergo a conformational change 
from the 3'-stacked conformation found in the crystal structure of tRNA^he 
(Fig. 1), to a structure with the anticodon stacked on the 5' side of the 
loop. 
To further characterize the role of the 3'-terminal adenosine in 
GpUpApA, tetranucleotides which contain the codon GpUpA and a 3'-nucleo­
tide that is not complementary to FUra-33 were constructed, and their 
effects on the ^®F NMR spectrum of (FUra)tRNA][®^ were investigated. 
GpUpApC and GpUpApU are complementary to the anticodon of tRNA][®^ but 
contain 3'-terminal pyrimidines, which are not complementary to FUra-33. 
As can be seen in Figure 22, addition of GpUpApU to (FUra)tRNAK®^ causes a 
progressive upfield shift of peak H, at 3.9 ppm, similar to that seen with 
GpUpA. Peak F (4.5 ppm), however, does not shift downfield as a result of 
GpUpApU binding to the tRNA (Fig. 22). Similar results were obtained when 
GpUpApC was used (data not shown), and a binding constant of 3025 was 
determined by Scatchard analysis. Figure 23 shows the effect of a 3'-
terminal guanosine, which may be capable of forming a G-U base with 
FUra-33, and should be more efficient than a pyrimidine in stabilizing 
oligonucleotide binding as a 3'-dangling-end (Westhof et al., 1983). 
Addition of GpUpApG to (FUra)tRNAj®^ again causes peak H to shift upfield 
(Fig. 23). In this case, the binding has the characteristics of a slow 
exchange with intensity decreasing at 3.90 ppm while it increases upfield 
at 3.23 ppm (indicated by an arrow in Fig. 23). Scatchard analysis of 
this interaction yields a binding constant of ca. 5500 M"^. Again, Peak F 
at 4.5 ppm does not shift downfield upon addition of GpUpApG (Fig. 23). 
These findings support the view that the effect of GpUpApA on the ^^F 
resonance at 4.5 ppm in the spectrum of (FUra)tRNA][®^ is not simply due to 
the presence of a 3'-dangling end on GpUpA, but is specific for the 
Figure 22. NMR spectra of (FUra)tRNA-[®^ before (A) and after 
addition of 0.3 mM (B); 0.6 mM (C); and 1.0 mM (D) 
GpUpApU. Spectra were recorded in standard buffer (see 
Methods). The concentration of (FUra)tRNA-[®^ was 0.17 mM. 
Asterisks indicate the position of peak H in each spectrum 
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Figure 23. NMR spectra of FUra-substituted tRNA^^^ before (A) and 
after addition of 0.26 mM (B); 0.78 mM (C); and 1.3 mM (D) 
GpUpApG. Spectra were recorded in standard buffer (see 
Methods). The concentration of (FUra)tRNA|[®^ was 0.35 mM. 
Arrow indicates shifted position of peak H 
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3'-tenninal adenosine, which is complementary to FUra-33. 
Formation of an anticodon-anticodon complex 
The anti codons of E. ooH tRNAp** (anti codon QUA, where Q is a modi­
fied guanosine) and FUra-substituted tRNA^®^ (anticodon FAC) are comple­
mentary and can form a highly stable complex by hydrogen bonding between 
their anticodons (Eisinger, 1971). The binding constants for such 
anticodon-anticodon complexes are several orders of magnitude greater than 
those for oligonucleotides binding to the anticodon loop, and this inter­
action has been used as a model for codon-anticodon interaction on the 
ribosome (Grosjean et al., 1976). Addition of an equimolar amount of 
tRNA2^^ to (FUra)tRNAi*1 causes peak H at 3.9 ppm to shift upfield to ca. 
3.2 ppm (Fig. 24). The observed shift agrees with the maximum shift 
determined for GpUpA binding, and is the result expected for a tight 
codon-anticodon Interaction. This result again supports the assignment of 
peak H to FUra-34 in the anticodon of (FUra)tRNA][®^. 
Significant broadening of all the resonances in the ^®F spectrum of 
the complex was observed, which is consistent with a decrease in rota­
tional correlation due to the increased molecular weight of the tRNA:tRNA 
complex. The ^®F signal at 4.5 ppm does not shift downfield upon forma­
tion of the anticodon-anticodon complex, showing that this shift cannot be 
ascribed simply to a strong association between the anticodon and a 
complementary base sequence. 
Evidence that codon-containinq oligonucleotides bind to the anti codon loop 
NMR To confirm that the effects of codon-containing oligonucle­
otides are caused by binding to the anticodon of (FUra)tRNA][®^, NMR 
studies of the methyl proton resonances in the tRNA were undertaken. 
(FUra)tRNA2®^ contains m^A at position 37, 3'-adjacent to the anticodon. 
Codon binding to the anticodon should perturb the proton resonances of the 
105 
D 
—I I I I I I I t 
8 7 6 5 4 3 2 1 
CHEMICAL SHIFT [PPM FROM FUra ]  
Figure 24. NMR spectra of FUra-substituted tRNAj®^ recorded before 
(A) and after complex formation with E. ooli tRNA^/^ (B). 
Spectra were recorded in standard buffer, and the concen­
trations of the tRNAs was 0.3 mM each 
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methyl group. Geerdes et al. (1980a) showed that binding of the codon-
containing oligonucleotide UpUpCpA to tRNA^he of yeast or E. coli produces 
upfield shifts of the methyl resonances of the hypermodified base adjacent 
to the anticodon. The methyl region NMR spectrum of (FUra)tRNA][®^ 
contains proton resonances derived from the m^G at position 46 and the m^A 
in the anticodon loop. The methyl protons from these residues in tRNA][®^ 
have been assigned by Kastrup and Schmidt (1975, 1978) to resonances 3.82 
ppm (m^G) and 2.50 ppm (m®A) downfield from DSS in NMR spectra recorded 
at 27°C in 10 mM sodium phosphate pH 7.0. Figure 25 shows the NMR 
spectra of the methyl protons of (FUra)tRNA][®^ at 25°C in 30 mM sodium 
phosphate pH 6.0 before and after addition of GpUpApA. Upon addition of 
increasing amounts of oligonucleotide, the resonance originally at 2.48 
ppm shifts progressively upfield. Similar results are obtained with 
GpUpA, but addition of ApUpGpA, which is not complementary to the anti­
codon has no affect on the peak at 2.48 ppm (data not shown). The 
signal from the methyl group of m^G (3.80 ppm) was not affected by the 
addition of either GpUpApA or ApUpGpA. Perturbation of the resonance 
from the m®A methyl protons by GpUpA and GpUpApA indicates that these 
oligonucleotides are binding to the anticodon. 
Cleavage of dGpTpApA; (FUra)tRNA][^^ by ribonuclease H Ribonuclease 
H is an endonuclease that cleaves the RNA portion of DNA:RNA hybrids. 
This enzyme has been used to study the solution structure of a number of 
RNAs by determining which portions of the molecule are accessible to com­
plementary deoxyoligonucleotides binding, as measured by RNase H cleavage 
(Harris, 1979; Mankin et al., 1981; Reitueld et al., 1982). Binding of 
the deoxyoligonucleotide dGpTpApA to (FUra)tRNA^®^ produces an upfield 
shift of the same ^®F peak at 3.9 ppm (peak H) as does GpUpA and GpUpApA 
binding (Fig. 26). This result indicates that the deoxyoligonucleotide 
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Figure 25. 300 MHz NMR spectra of m^A methyl protons in FUra-
substituted tRNAj ^ (0.58 mM) before (A) and after addition 
of 0.28 mM (B) and 0.84 mM (C) GpUpApA. Conditions were 
30 mM sodium phosphate, pH 6.0, 20 mM MgCl2» and 100 mM NaCl 
in 100% ^HgO. Asterisks indicate impurities 
Figure 26. NMR spectra of (FUra)tRNA][®^ before (A) and after 
addition of 0.9 mM (B) and 2.7 mM (C) dGpTpApA. Spectra 
were recorded in standard buffer (see Methods). The tRNA 
concentration was 0.38 mM 
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binds to the same site on (FUra)tRNA][®^ as the codon-containing oligoribo-
nucleotides. Figure 27 shows that when the complex of the deoxyoligonu-
cleotide and end-labeled (FUra)tRNA][®^, formed under a variety of 
conditions, is hydrolyzed with RNase H, cleavage occurs at one major site, 
position 34 in the anticodon loop. This indicates that dGpTpApA binds 
only to the anticodon loop. It is, therefore, reasonable to conclude that 
GpUpA and GpUpApA also bind only to the anticodon loop. 
Influence of magnesium and spermine on codon-anticodon interaction 
Both magnesium and spermine serve to stabilize the conformation of 
the anticodon arm in the crystal structure of yeast tRNAfhe (Quigley et 
al., 1978). One spermine molecule is bound at the junction of the D and 
anticodon stems. The presence of this polycation has a noticeable effect 
on the conformation of the anticodon stem, producing a 26° kink in the 
double helix between the anticodon and D stems. The anticodon conforma­
tion is further stabilized by a magnesium ion bound to the upper part of 
the loop. Together these ligands significantly immobilize the anticodon 
loop (Teeter et al., 1980). 
The previous studies of oligonucleotide binding to the anticodon of 
(FUra)tRNAj®^ were done in the presence of 15 mM Mg** (no spermine). To 
determine the influence of magnesium and spermine on the codon-anticodon 
interaction, oligonucleotide codon binding to (FUra)tRNA^*1 was examined 
in the absence of Mg**, and in the presence of both spermine and magne­
sium. Addition of the codon GpUpA to (FUra)tRNA][®^ in the absence of 
Mg**, results in the upfield shift of ^®F resonances, at 3.29 and 3.89 ppm 
(Fig. 28). The chemical shift positions of these signals indicate they 
are peaks H and F, respectively (Fig. 9B). These are the same ^®F reso­
nances affected by codon binding in the presence of 15 mM Mg** (Figs. 18 
and 21). Both peaks shift upfield continuously as oligonucleotide is 
Figure 27. Ribonuclease H cleavage of end-labeled 
(FUra)tRNAj®^ Standard reactions mixtures contained 
0.5 pMol tRNA, 50 pmol dGpTpApA in 40 mM Tris-HCl, pH 7.9, 
8 mM MgClg, 2 mM DTT, and 30 ug/mL BSA. Ail reactions 
were incubated at 30°C for 30 min with 0.5 units RNase H 
(unless otherwise indicated). Lane 1: preincubated 30 min 
at 30°C without enzyme prior to start of reaction. 
Lane 2: reaction without preincubation. Lane 3: 100 mM 
NaCl added to the reaction mixture. Lane 4: reaction in 
NMR buffer: 50 mM sodium cacodylate buffer, pH 7.9, 15 mM 
MgCl2* 100 mM NaCl, 30 pg/wL BSA. Lane 5: Ribonuclease T1 
sequencing ladder. Lane 6; reaction lacking dGpTpApA. 
Lane 7: reaction without RNase H 
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Figure 28. Effect of GpUpA on the NMR spectrum of (FUra)tRNA-[®^ 
in the absence of magnesium. Spectra were recorded before 
(A) and after addition of 0.50 mM (B); 1.0 mM (C); and 
2.0 mM (D) GpUpA. Solution conditions were 50 mM sodium 
cacodylate buffer, pH 6.0, 100 mM NaCl, and 1 mM EDTA. 
The concentration of tRNA was 0.32 mM 
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added; however, peak H shifts nearly twice as far as peak F. Eventually, 
at 2 mM GpUpA, peak H has shifted 0.28 ppm while peak F has moved only 
0.15 ppm. 
When the tetranucleotlde GpUpApA Is added to (FUra)tRNA][®^ In the 
absence of Mg**, the same two resonances again shift progressively upfleld 
(data not shown). In this case, however, the magnitude of the shifts are 
approximately the same for each peak, with a maximum shift of nearly 0.5 
ppm upon addition of 1.4 mM GpUpApA. 
These results contrast with those observed for tri- and tetranucleo­
tlde codon binding to (FUra)tRNA|[®^ In 15 mM Mg** (Figs. 19 and 21). In 
the presence of Mg**, GpUpA binding Induces the upfleld shift of only peak 
H, whereas GpUpApA Induces peak F to shift downfleld In addition to the 
upfleld shift of peak H. The association constants for GpUpA and GpUpApA 
binding to (FUra)tRNAi*1 are much lower in the absence of Mg"*^; both are 
estimated at ca. 300 M"^ by Scatchard analysis (data not shown). The 
results obtained in the absence of magnesium are consistent with an alter­
nate anticodon loop conformation in the absence of the cation (see 
Discussion). 
Figure 29 shows the effect of GpUpApA binding on the ^^F NMR spectrum 
of (FUra)tRNAi*1 in the presence of spermine (and 15 mM Mg"*^). Increasing 
amounts of GpUpApA shift peak H (3.8 ppm) upfleld to 3.16 ppm, which again 
agrees with the maximum of shift peak H, 0.69 ppm, calculated for GpUpA 
binding. Peak F (4.5 ppm) does not shift downfleld as occurs upon GpUpApA 
binding to (FUra)tRNAi®^ in 15 mM Mg** without spermine (Fig. 21). It is 
possible that spermine stabilizes a conformation of the anticodon loop in 
which the 3'-term1nal adenosine of GpUpApA cannot Interact with FUra-33. 
Addition of spermine to FUra-substituted tRNAj®^ in the presence of 
MgCl2 (15 mM) was shown to cause a downfleld shift of one ^®F resonance in 
the G/H region (Fig. 15). The peak that shifted was difficult to identify 
Figure 29. Effect of GpUpApA on the NMR spectrum of (FUra)tRNAy®^ 
in the presence of spermine. Spectra were recorded before 
(A) and after addition of 0.85 mM (B); 1.7 mM (C); and 
3.4 mM (D) GpUpApA. The tRNA (0.32 mM) was dissolved in 
standard buffer (including 15 mM Mg**) with 2.10 mM 
spermine 
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because peaks G and H overlap. The upfleld shift of the peak at 3.8 ppm 
upon addition of GpUpApA in the presence of spermine (Fig. 29) indicates 
that this is peak H and that peak G is the resonance shifted downfield by 
spermine (Fig. 15). 
Codon-anticodon interaction in FUra-substituted methionine tRNAs 
FUra-substituted methionine tRNAs also contain a FUra residue in 
their anticodon. In this case, the FUra is located in the 3' position of 
the anticodon as opposed its 5' location in (FUra)tRNA^*T. ^®F NMR 
studies of codon binding to FUra-substituted tRNA^J}®^ show that one ^®F 
resonance, originally at 4.2 ppm (peak I), shifts progressively upfield 
upon addition of increasing amounts of the codon ApUpG (Fig. 30). 
Analysis of a double reciprocal plot of the binding curve indicates 0.16 
ppm as the maximum shift in the position of peak I at infinite [ApUpG], 
and Scatchard analysis of these data yields a binding constant of 1200 
at 20°C and 0.1 M NaCl (data not shown but similar to Fig. 19). The 
calculated binding constant agrees well with the previously reported value 
of 1700 for this interaction, as determined by equilibrium dialysis at 
2°C and 0.2 M NaCl (Hogenauer et al., 1972). Addition of GpUpApA did not 
effect this peak (data not shown). The chemical shift of peak I (4.2 ppm) 
is similar to the position of peak H (3.9 ppm) In the ^®F NMR spectrum of 
(FUra)tRNA-[®^ which, also shifts upfield upon addition of codon (Fig. 18). 
In contrast to the results seen with tRNA^^t, addition of the codon 
ApUpG has no effect on the ^®F NMR spectrum of 5-fluorourac11-substituted 
tRNA^^ (Fig, 31), even when the codon is added in 6-fold molar excess. 
Addition of the codon-containing tetranucleotide ApUpGpA also has no 
effect on the ^®F spectrum of (FUra)tRNA^®^ (results not shown). These 
results indicate that (FUra)tRNA^®^ either does not bind the oligonucleo­
tide codons, or that the interaction does not result in a visible change 
Figure 30. NMR spectra of FUra-substituted tRNAjJj®^ recorded 
before (A) and after addition of 0.84 mM (B); 1.68 mM (C); 
and 3.4 mM (D) ApUpG. Spectra were recorded in standard 
buffer. The concentration of (FUra)tRNA{j|j®^ was 0.43 mM 
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Figure 31. NMR spectra of FUra-substituted tRNA^®^ recorded 
before (A) and after addition of 0.90 mM (B) and 1.8 mM 
ApUpG. Spectra were recorded in standard buffer. The 
concentration of (FUra)tRNA^®^ was 0.48 mM 
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in the spectrum. 
NMR study of possible conformational change resulting from codon-
anticodon interaction 
Conformational changes in distant parts of the tRNA molecule have 
been attributed to association of codon with the anticodon. In partic­
ular, it has been suggested that the interactions between the T and D 
loops are disrupted upon codon binding (Schwarz et al., 1976; Schwarz and 
Gassen, 1977). 
In 5-fluorouracil-substituted tRNA^®^ the TpVpCpG sequence is 
replaced by FpFpCpG since FUra replaces ribothymidine and pseudouridine. 
If this sequence is exposed then binding of CpGpApA should perturb the ^^F 
resonances from these FUras in the spectrum of (FUra)tRNA][®^, much as 
binding of codon-containing oligonucleotides affects ^^F signals from FUra 
residues in the anticodon loop (Figs. 18, 21 and 30). Figure 32 shows the 
^^F NMR spectrum of (FUra)tRNAin the absence (A) and presence (B) of 
CpGpApA, and after addition of both CpGpApA and GpUpA (C). No significant 
changes in the spectrum occur upon addition of CpGpApA alone, and in the 
presence of both codon and CpGpApA the only change is the upfield shift of 
the ^^F resonance originally at 3.90 ppm, which is the same effect seen in 
Figure 18 for addition of GpUpA alone. These results indicate that the 
FpFpCpG sequence in the T loop of (FUra)tRNA][®^ is not available for 
binding to a complementary oligonucleotide, and that codon binding does 
not induce a conformational change which makes this sequence available for 
oligonucleotide binding. 
Figure 32. NMR spectra of (FUra)tRNAy®^ recorded before (A) and 
after addition of 2 mM CpGpApA (B) and 2 mM CpSpA-A plus 
3.5 mM GpUpA. Spectra were recorded in standard buffer. 
The concentration of tRNA was 0.66 mM 
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DISCUSSION 
E. coli tRNA{[|®* is the third 5-fluorouracil-substituted transfer RNA 
to be purified and its NMR spectrum obtained. Like the first two, 
tRNA^al (Horowitz et al., 1974) and tRNA^®^ (Hills et al., 1983), this 
analogue substituted molecule, with over 90% of its uracil and uracil-
derived constituents replaced by FUra (Table 3), appears to be fully 
recognized by its cognate synthetase and aminoacylated to an extent 
comparable to normal tRNA^^*, Thus, these analogue substituted tRNAs 
present useful systems for investigation by NMR. 
The ^^F NMR spectrum of (FUra)tRNA|j|J®^ (Figure 6) contains 13 well 
resolved resonances and several shoulders derived from the 18 fluoro-
uracils in the molecule. The range of chemical shifts for the ^®F reso­
nances in the spectrum of (FUra)tRNAjJ|®^, from 0.3 to 8.0 ppm downfield 
from free FUra(= 0 ppm), is similar to that seen in the spectra of FUra-
substituted tRNAj®^ (Fig. 3A) and tRNA^^t (pig. 3B). This dispersion of 
the ^®F signals has been shown to be due to the folding of the tRNA mole­
cule into its native three-dimensional structure. When the secondary and 
tertiary structure of (FUra)tRNA][®^ are disrupted, the ^^F NMR spectrum 
collapses into a single peak at 4.7 ppm, corresponding to the central 
portion of the native spectrum (Hardin et al., 1986). The ^®F NMR 
spectrum of poly(FU) (random coil) also yields a single peak at 4.5 ppm 
(Hardin et al., 1986). These observations indicate that the chemical 
shifts of the ^^F resonances in the spectra of native FUra-substituted 
tRNA reflect the different environments of each FUra residue, due to the 
structure of the folded molecule. 
The overall appearance of the spectrum of (FUra)tRNA}[}®^ (Fig. 6) is 
also similar to that of FUra-substituted tRNAj®^ (Fig. 3A) and of tRNA^®^ 
(Fig. 3B). In each spectrum, there is a group of peaks between 4.0 and 
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5.0 ppm, close to the chemical shift position of heat denatured (FUra)tRNA 
and poly(FU) (random coil). These signals presumably correspond to FUra 
residues in relatively unstructured regions of the native tRNA molecule, 
i.e., nonbase-paired FUra residues. The ^®F spectra of all three tRNAs 
also contain a group of peaks upfield of the central region (ca. 0.5-3.8 
ppm), and several resolved resonances downfield of 5.0 ppm. It has been 
proposed (Horowitz et al., 1977) that the downfield resonances represent 
FUra residues involved in tertiary interactions, and that the group of 
signals in the upfield portion of the spectra correspond to FUra residues 
in helical environments. 
A comparison of the number of FUra residues in each environmental 
classification in each tRNA, based on analogy to the crystal structure of 
tRNA^he (Rich and RajBhandary, 1976), and the relative areas of the ^^F 
signals in the various regions of the spectra, shows a good correlation 
between structure and chemical shift for FUra-substituted tRNAj®^ and 
tRNAfCt. Both molecules contain three FUra residues involved in tertiary 
interactions (Fig. 2), and both ^®F spectra contain three peaks in the 
downfield region, between ca. 5.5 and 8.0 ppm (Fig. 3). The ^®F spectra 
tRNA-[®^ and tRNA^®^ show 6, and 3 signals upfield of the central group of 
peaks, respectively, and this corresponds to the number of FUra residues 
in helical regions in each of these fluorinated tRNAs. The number of ^^F 
signals in the central group of peaks in the spectra of (FUra)tRNA2®^ and 
(FUra)tRNA^Gt also agrees with the number of non-hydrogen-bonded FUra 
residues in each tRNA. 
In the case of FUra-substituted tRNA{J|®^, the groupings do not appear 
to correlate as well. The downfield region of the spectrum contains peaks 
A-D with a total area of four fluorines (Fig. 6), but there are only three 
FUra residues involved in tertiary interactions in this molecule (Fig. 2). 
There are 7 secondary base-paired, and 8 non-hydrogen-bonded FUra residues 
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in (FUra)tRNAMGt (Fig. 2), and these numbers do not correlate well with 
the number of resonances in the upfield and central regions of the 
spectrum, respectively (Fig. 6). This indicates that factors other than 
involvement of the FUra residues in primary, secondary, or tertiary struc­
tures are involved in determining the chemical shift positions of ^®F 
peaks from FUra residues in tRNA. It should be pointed out that few 
studies have been done with FUra-substituted tRNAjJ}®^, and more investiga­
tion is required before the significance of the grouping of peaks in the 
^®F spectrum of this tRNA can be understood. 
All three purified FUra-substituted tRNAs can be resolved into two, 
fully active, isoaccepting species termed the A and B forms of each 
analogue substituted tRNA. ^®F NMR spectra of the A and B forms of each 
tRNA differ mainly by the shift of one peak from between 4.6 and 4.8 ppm 
in the spectrum of isoacceptor B to ca. -15 ppm in the spectra of form A 
(Figs. 2 and 6). The ^^F signal at -15 ppm has been shown to be due to a 
ring-opened 5-fluoro-5,6-dihydrouridine substituent present in the A form 
of these tRNAs (Horowitz et al., 1983). 
The modified FUra has been located at position 20 in (FUra)tRNA^®^ by 
sequence analysis of the two isoacceptors (Hills et al., 1983), and on 
this basis, a resonance at 4.8 ppm (Peak E) in the ^®F NMR spectrum of 
(FUra)tRNA^Gt form B (Fig. 3B) has been assigned to FUra 20, normally 
occupied by the only dihydrouridine in tRNA^®^. Aniline cleavage at pH 
4.5 has located the modified fluorodihydrouridine in FUra-substituted 
tRNAj®^ at position 17 (Fig. 7). This allows assignment of peak D in the 
^^F NMR spectrum of (FUrajtRNAi^l form B to FUra-17 in the D loop of the 
tRNA. This position is also the site r. the only dihydrouridine in this 
molecule. E. aoli tRNA^Gt normally contains dihydrouridine residues at 
positions 17, 20, and 20a, and a partial modification at position 16 (Cory 
and Marker, 1970). Aniline treatment of the A form of 5'-^^P end-labeled 
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(FUra)tRNAMet results in only one major cleavage in the D loop, at posi­
tion 20, indicating only one modified fluorodihydrouridine occurs in this 
tRNA (at position 20). It is, therefore, possible to assign the reso­
nance at 4.6 ppm (peak F) to FUra-20 in (FUra)tRNAU|®^. The results of 
aniline treatment of clearly show that positions 16 and 17 of 
(FUra)tRNAMbt, which normally contain dihydrouridine, are not reduced to 
fluorodihydrouridine. Modification at position 20a cannot be completely 
ruled out because the tRNA was labeled at the 5' end. However, since the 
aniline cleavage conditions used, resulted in only partial cleavage of the 
polynucleotide backbone, it is unlikely that position 20a is modified. 
Evidently, the enzyme responsible for dihydrouridine synthesis only recog­
nizes FUra in position 20 of (FUra)tRNA|jJ®^. This may mean that more than 
one enzyme catalyzes formation of dihydrouridine in E. coli tRNAs, and 
only one of these enzymes can recognize FUra. 
Examination of the Effects of Solution Conditions and Chemical Reactivity 
of the ^^F Resonances in the Spectra of FUra-Substituted tRNA 
Examination of the effects of solution conditions and chemical reac­
tivity of ^^F resonances in the spectra of purified FUra-substituted tRNAs 
provides an initial approach to assigning the ^®F peaks in the spectra to 
individual FUra residues in the molecules. Eventually, these studies may 
also yield valuable information regarding the conformational states of 
tRNA solution. 
Because ^®F NMR spectra of heat denatured (FUra)tRNA, and poly(FU) 
(random coil) show a single peak at ca. 4.7 ppm (Hardin et al., 1986), it 
has been suggested that the groups of peaks in the central portion (3.9-
5.0 ppm) of the ^^F NMR spectra of (FUra)tRNAs represent FUra residues in 
relatively unstructured (loop) regions of the native tRNA molecule. 
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Several studies presented here support this assignment. 
The pH dependence of the NMR spectrum of (FUra)tRNA][®^ (Fig. 8) 
shows that FUra residues D, E, F, and H are susceptible to titration and 
exhibit pKas near that of free FUrd, indicating that these FUra residues 
are exposed to solvent. The chemical shift of one peak in the central 
portion of the spectrum (peak G) is, however, unaffected by changes in pH. 
Two resonances in the spectrum shift in the acid pH range. Peak C, 
shifts downfield, and one peak, at 4.5 ppm (labeled F) shifts up field at 
pHs between 4.5 and 5.5 (Fig. 8B). Peak C at 5.5 ppm, also shifts down-
field with increasing pH, but the extent of this shift is not as great as 
that of the other peaks, and several other studies, including measurement 
of the solvent isotope shift (SIS) (Hardin et al., 1986) and reaction with 
bisulfite (see below) Indicate FUra C is not exposed to solvent. These 
findings suggest that the downfield movement of peak C with increasing pH 
is not due to ionization of FUra C. Peaks E and F merge between pH 5.5-
6.0, and this makes it difficult to identify which of the two shifts at 
low pH. However, addition of GpUpApA to (FUra)tRNA][®^ at pH 4.5 shifts 
the resonance at 5.2 ppm, which indicates that it is peak F which is 
affected by low pH (data not shown). Several studies have shown that a 
structural change occurs in tRNA at mildly acidic pH (Bina-Stein and 
Crothers, 1975; Steinmetz-Kayne et al., 1977). The shift of peak C, and 
especially the downfield movement of the peak F (Fig. 8) may reflect this 
structural change. Peak F has been assigned to FUra 33, and this suggests 
that the structure of the anticodon loop is affected by acidic pH. 
The same FUra residues, those corresponding to peaks D, E, F, and H, 
in the central portion of the spectrum of (FUra)tRNA][®^ that are suscep­
tible to pH titration, react with bisulfite, a single-strand specific 
reagent (Fig. 16). This finding is a further indication that these FUra 
residues are located in nonbase-paired regions of the tRNA. Again, peak G 
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is an exception, being the only resonance in the 3.9 to 5.0 ppm range that 
is not affected by bisulfite reaction. Measurement of the solvent isotope 
shift (SIS) on transfer of the tRNA from HgO to ^HgO also shows that FUra 
residues D, E, F, and H are completely exposed to solvent, whereas FUra G 
appears to have little or no contact with the solvent (Hardin et al., 
1986). 
FUra-substituted tRNAj®^ contains 5 non-base-paired FUra residues 
(Fig. 2). The results of pH titration (Fig. 8) and reaction with bisul­
fite (Fig. 16), along with SIS measurements (Hardin et al., 1986) allow 
assignment of four of these residues to peaks D, E, F, and H, all in the 
central region of the ^®F spectrum. Peak D has been assigned to FUra 17 
in the D loop based on comparison of the two isoaccepting forms of 
(FUra)tRNA^®^ (Fig. 7), and peaks F and H have been assigned to the two 
FUra residues in the anticodon loop based on oligonucleotide binding 
studies (Figs. 18 and 21; also see later Discussion). All of these 
assigned FUra residues are located in single-stranded regions of the tRNA. 
There are two more non-hydrogen-bonded FUra residues in (FUra)tRNAi[®^ and 
only one more fluorouracil, FUra E, with single-stranded characteristics, 
i.e., susceptible to pH titration, bisulfite reactive and showing a high 
SIS. Peak G is also found in the central group of resonances in the ^®F 
spectrum, suggesting that FUra G may be the fifth single-stranded FUra in 
the tRNA. However, FUra 6 is not titratable (Fig. 8) nor does it react 
with bisulfite (Fig. 16). A possible candidate for FUra G is position 59 
in the T loop. This base is in a single-stranded region of the tRNA, but 
a number of chemical modification studies show that this position has 
little reactivity with a variety of chemical reagents (reviewed by 
Goddard, 1977), and that in general, the T loop is buried in the tertiary 
structure of the molecule (Vlassov et al., 1981; Romby et al., 1985). 
Studies of spermine binding to (FUra)tRNA-[®^ show that peak G is specifi­
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cally affected by the polyamine (Fig. 14), which suggests that FUra G may 
be located at position 8, based on comparison to NMR studies of sper­
mine binding to tRNA (Hyde and Reid, 1985; also see later Discussion). 
Clearly further investigation is required to make any assignment of peak 
G, and this assignment will be quite interesting considering the unusual 
behavior displayed by this ^®F signal. 
The ^®F spectra of all three purified FUra-containing tRNAs contain 
several resolved resonances downfield (5.5-8.0 ppm) from the central 
cluster of peaks. Based on the relative areas of the downfield resonances 
in ^®F spectra of both unfractionated FUra-containing tRNA and of 
(FUra)tRNA2®^, Horowitz et al. (1977) suggested that these downfield reso­
nances correspond to FUra residues involved in tertiary interactions in 
the tRNA molecule. Several recent observations support this hypothesis. 
The downfield resonances are the first to melt as the temperature Is 
raised (Hardin, 1984), and therefore, are likely to represent FUra 
residues involved In tertiary hydrogen-bonding since the tertiary struc­
ture has been shown to be the most labile in some tRNAs (Crothers and 
Cole, 1978). However, Interpretation of these results is complicated 
since recent ^H NMR studies that shown that in some tRNAs the tertiary 
interactions are not always the most labile (Johnson and Redfield, 1981; 
Roy and Redfield, 1983). 
19f{19fj nuclear Overhauser studies have provided evidence that the 
two farthest downfield peaks in the ^®F NMR spectrum of (FUra)tRNA][®^ 
represent FUra 54 and FUra 55 in the T loop (Hardin, 1984); both of these 
bases are involved in tertiary interactions (Fig. 2). These studies show 
a reciprocal NOE between peaks A and B, and based on the structure of 
yeast tRNAf^G, pUra 54 and FUra 55 are the only two FUra residues close 
enough to each other (4-5 A) to allow an appreciable homonuclear NOE. 
Evidence for assignment of peak B to FUra 54, which replaces the 
133 
invariant ribothymidine in the T loop, has been provided by NMR 
studies of thermal denaturation of (FUra)tRNA][®^, in the absence of Mg** 
(Hardin, 1984). As the temperature is increased above 30°C, peak B grad­
ually shifts from 6.6 to 6.4 ppm. Peak B is split into two signals during 
this transition indicating that FUra B exists in two distinct states that 
exchange slowly. This behavior resembles splitting observed in the methyl 
proton resonance of rT 54 in native tRNAj®^ (Kastrup and Schmidt, 1975, 
1978; Davanloo et al., 1979) and in the ^^C-methyl signal of rT 54 in 
several tRNAs (Kopper et al., 1983). Based on this similarity, peak B in 
the ^^F spectrum of (FUra)tRNA2®^ has been tentatively assigned to FUra 54 
(Hardin, 1984). A preliminary assignment of peak A to FUra 55 can also be 
made, based on the NOE studies mentioned earlier. 
NMR spectra of FUra-substituted tRNA also contain a group of 
resonances located upfield of the central cluster of peaks (0.5-3.5 ppm). 
Several lines of evidence support the hypothesis that these resonances 
correspond to FUra bases in helical structures in the tRNA. 
The primary effect of HMT photoaddition to (FUra)tRNA-[®^ is reduction 
of the intensity of peaks J and L, in the upfield region of the ^^F spec­
trum (Fig. 17). Because psoralens are known to react preferentially with 
pyrimidines in helical structures (Cimino et al., 1985), this result 
suggests that the FUra bases corresponding to the upfield peaks are 
located in base-paired stems of the tRNA. The intensity of peak A also 
decreases substantially upon photoreaction with HMT (Fig. 17). This reso­
nance has been tentatively assigned to FUra 55 in the T loop. Pseudouri-
dine 55, and several of the adjacent bases, are involved in tertiary base-
pairs (Fig. IB). It is possible that these tertiary Interactions create 
an environment which allows the psoralen to intercalate and photoreact 
with FUra 55. This position is not reactive with HMT in E. ooli tRNA^he 
(Bachellerie and Hearst, 1982), however, pseudouridine in position 55 of 
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this tRNA is not reactive with psoralen, whereas 5-fluorouracil in the 
modified tRNA is photoreactive. 
Additional evidence to support the assignment of the upfield peaks to 
FUra residues in helical environments is provided by the observation that 
ethidium bromide specifically affects resonances L and N at 2.5 and 1.9 
ppm, respectively, in the ^®F spectrum of (FUra)tRNA(W. C. Chu and J. 
Horowitz, Dept. of Biochemistry and Biophysics, Iowa State Univ. unpub­
lished results). NMR studies have shown that the imino proton from the 
A6-U67 base-pair in the acceptor stem of tRNAj®^ is the most sensitive to 
interaction with ethidium bromide (B. Reid, Dept. of Chemistry, Univ. of 
Washington, personal communication). 
The results discussed in this section have allowed a correlation to 
be drawn between the various regions of the ^®F NMR spectrum of 5-fluoro­
uracil -substituted tRNAs and the FUra residues in different environments 
in the tRNA. This will allow general interpretation of effects on the ^®F 
spectra of these tRNAs and will pave the way for future experiments to 
make more specific assignments. 
Ion binding ^ FUra-substituted tRNA 
The resonances in the ^®F NMR spectra of purified FUra-substituted 
tRNAs exhibit different degrees of sensitivity to changes in cation 
concentration. Peak A, the farthest downfield resonance in the spectra of 
each fluorinated tRNA, is the most sensitive to changes in monovalent and 
divalent cation concentration (Figs. 9, 10 and 12). This appears to be a 
characteristic of all FUra-substituted tRNAs, and may indicate that peak A 
corresponds to an invariant base substituted by fluorouracil. Redfield 
and collaborators (Johnson and Redfield, 1981; Tropp and Redfield, 1981) 
have observed a resonance in the NMR spectra of several tRNAs that also 
exhibits a hypersensitivity to changes in Mg**. This peak has been 
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assigned to the imino proton at N(l) of Y55. The fluorine atom in FUra 55 
is located at the same position normally occupied by the N(l)-H of Y55. 
These observations suggest that peak A in the spectra of all three 
purified fluorinated tRNAs can be assigned to FUra 55, which replaces the 
invariant pseudouridine in the T loop of all tRNAs. This assignment 
agrees with the previous assignment of peak A in the ^®F spectrum of 
(FUra)tRNAj®^ to FUra 55, based on the ^^F{^®F} homonuclear NOE observed 
between peaks A and B in the ^®F NMR spectrum of (FUra)tRNA][®^ (Hardin, 
1984). 
There is one additional resonance, in the central portion of the ^®F 
spectra of all three purified (FUra)tRNAs, that is sensitive to changes in 
[NaCl] (Figs. 9 and 10). These peaks are labeled F, I, and I in the 
spectra of FUra-substituted tRNA^®^, tRNA^®^, and tRNAjJ®^, respectively. 
Two of these resonances, those in (FUrajtRNAj^^ and (FUrajtRNA^Gt, have 
been assigned to FUra residues in the anticodon loops of these tRNAs based 
on oligonucleotide binding studies (Figs. 21 and 30). This suggests that 
the conformation of the anticodon loop may be affected by salt concentra­
tion. Addition of an oligonucleotide codon to (FUra)tRNA^®^ does not 
affect the ^^F NMR spectrum of the initiator tRNA (Fig. 31) as codon bind­
ing does with the fluorinated elongator tRNAs (Figs. 18 and 30). There 
is, however, one resonance in the 4.0-5.0 ppm range of the ^®F spectrum of 
(FUra)tRNAfGt, peak I, that shifts upfield with increasing [NaCl]. 
Because the chemical shift position of this resonance is similar to the 
signals assigned to the anticodon of (FUrajtRNA^Gt and (FUra)tRNA][®^, and 
since all of these peaks display similar behavior with respect to changing 
[NaCl], it is likely that peak I in the ^^F NMR spectrum of (FUra)tRNA^Gt 
also represents the FUra residue in the anticodon of the initiator tRNA, 
FUra 36. 
Examination of the magnesium dependence of the chemical shift posi­
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tions of the resonances in the spectrum of (FUra)tRNAj®^ (Fig. 12B) 
has aided in determining the location of all the signals in the spectrum 
obtained at high magnesium concentration. This is especially true for 
peaks K and F, which are not resolved in the high magnesium spectrum but 
are in the absence of Mg"*^. The spectra recorded between 30 and 50 
Mg**/tRNA clearly show that, at high levels of Mg**, there are three ^®F 
resonances in the cluster of peaks between 4.3 and 4.7 ppm (labeled D, 
E/F), however, the exact location of peak F at the highest concentration 
of magnesium is difficult to specify. 
A fractional peak is often seen at 4.85 ppm in the ^^F spectrum of 
FUra-substituted valine tRNA (visible in several of the spectra presented 
in this study). This small peak is visible at all levels of magnesium and 
is not affected by changes in divalent cation concentration (Fig. 12A). 
The significance of this peak is not clear at present. It has been 
suggested that it may represent a small percentage of a denatured form of 
the tRNA, because the chemical shift position of this ^®F peak is nearly 
identical to that of heat denatured (FUra)tRNA-[®^ (C. C. Hardin, Dept. of 
Chemisty, Univ. of California, personal communication). 
Examination of the effects of paramagnetic metal-ion binding to tRNA 
can aid in assigning resonances in the NMR spectra (Hurd et al., 1979; 
Schweizer, 1980). Resonances from fluorines close to the ion binding site 
are affected most by the bound paramagnetic ion. Crystallographic studies 
have shown that Mn** binds to the hinge region of tRNA^he where the D and 
T loops interact (Fig. IB) (Jack et al., 1977). The manganese is bonded 
directly to the N7 of G20, and water ligands of the manganese ion form a 
number of hydrogen bonds with nearby residues (Jack et al., 1977). NMR 
studies indicate that, in solution, the initial binding of manganese is 
near the s^U8-A14 and G15-C48 tertiary hydrogen bonds, and based on this 
observation is was suggested thct Mn** binds on the other side of the 
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hinge region, near phosphates 8 and 9 (see Fig. IB) (Hurd et al., 1979). 
NMR studies of [4-^^C] uracil-enriched tRNA-[®^ have also shown that 
resonances from uracils in and around the hinge region of the tRNA are 
affected by Mn** binding (Schweizer, 1980). 
Peaks J, L, and N, in the upfield portion of the ^®F spectrum of 
(FUra)tRNA][®^, are the most sensitive to Mn** binding. This indicates 
that these resonances may be from FUra residues located near the hinge 
region of tRNAj®^, which includes residues 8, 12, 47, and possibly 7, and 
59 (Fura 17 is also in this region of the molecule but has already been 
assigned to peak D, which is not affected by Mn**). Peak J is also 
affected by Mg** (Fig. 12) but not by monovalent Na"*" (Fig. 10) or the 
polycation spermine (Fig. 14). This resonance is among those most 
affected by photoreaction with HMT (Fig. 17) indicating FUra J is located 
in a helical region of the tRNA. Peak N and especially peak L are specif­
ically affected by ethidium bromide (Chu and Horowitz unpublished observa­
tions), which suggests that these FUra residues are located in the 
acceptor stem based on comparison to results of NMR studies (B. Reid 
personal communication); possibly FUra 7 and 67, which are the closest 
FUra residues in the acceptor stem to the hinge region. 
The two other ^®F resonances that are paramagnetically broadened by 
Mn** are peaks A and B. These resonances have been tentatively assigned 
to FUra 55 and 54 respectively, in the T loop of the molecule. Interest­
ingly one of these two ^^F signals, peak A, is hypersensitive to changes 
in cation concentration (Figs. 12 and 10), whereas the other, peak B, is 
very insensitive to changes in the concentration of cations (Figs. 12 and 
10). NMR studies also detect paramagnetic broadening of signals from 
residues 54 and 55 in [4-^^C] uracil-labeled E. ooli tRNAj®^. (Schweizer, 
1980). 
Two bound spermine molecules are found in the crystal structure of 
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tRNA^he (Fig. IB), one bound to the anticodon stem, and the other is found 
near the variable loop. Hyde and Reid (1985) found specific effects of 
spermine on the NMR spectrum of E, aoH tRNAf^e occurring at base-pairs 
615-C48 and s^U8-A14. Addition of spermine to (FUra)tRNA|[®^ affects three 
resonances in the spectrum (Fig. 14). Peak A, (tentatively assigned 
to FUra 55) shifts upfield with increasing spermine. This appears to be a 
nonspecific effect since this resonance shows similar behavior upon 
increasing [NaCl] (Fig. 10) or upon removal of Mg** (Fig. 12). The other 
two spermine sensitive resonances are peaks G and I. One of these reso­
nances may represent FUra 8, which is the closest FUra base to the region 
affected by spermine in the proton NMR studies (Hyde and Reid, 1985). 
However, further studies are clearly required to assign a ^^F signal to 
position 8 in (FUra)tRNAj®^. It is interesting to note that peak G is the 
one ^®F signal in the central portion of the spectrum that is not sensi­
tive to changes in pH (Fig. 8) or reactive with bisulfite (Fig. 16). 
Codon Anticodon Interaction in FUra-Substituted tRNAs 
Because the accuracy of translation is dependent on proper recogni­
tion of a codon by its complementary anticodon, the codon-anticodon inter­
action is one of the most important steps in protein synthesis. In this 
study, ^®F NMR was used to investigate the interaction of FUra-substituted 
transfer RNA with oligonucleotide codons. The results permit assignment 
of several ^^F resonances in the spectra to a FUra residue in the anti­
codon of fluorinated tRNA^®^ and tRNAjj}®^, and the determination of binding 
constants for the interaction between these tRNAs and oligonucleotide 
codons. The results also provide information about the structure of the 
anticodon loop. 
Addition of codon GpUpA to (FUra)tRNA-[®^ results in the upfield shift 
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of a single resonance at 3.9 ppm (Fig. 18). Measurement of the shift 
as a function of GpUpA concentration allows determination of an associa­
tion constant of 2500 M"^ (Fig. 19), which Is just slightly lower than a 
previously reported value of 3000 for the association of GpUpA with 
normal tRNA^®^ (Pongs and Griese, 1972). The difference could be due to 
the lower temperature and higher salt concentration used by Pongs and 
Griese (1972), as both conditions are known to increase the affinity 
constants of these interactions (Uhlenbeck, 1972). Normal tRNA][®^ has a 
modified nucleoside, ur1d1ne-5-oxyacetic acid, at position 34 in the anti-
codon, whereas In (FUra)tRNA2®^ this is replaced by 5-fluorour1dine 
(Horowitz et al., 1974). This substitution does not appear to signifi­
cantly affect the affinity of codon. 
The sequence complementary to GpUpA occurs only once In tRNA-[®^, at 
the anticodon. This fact, together with the observation that trinucleo­
tides not complementary to the ant1codon do not shift the ^®F resonance at 
3.90 ppm, and the close agreement of the binding constant determined in 
these studies with the value in the literature, determined by equilibrium 
dialysis, indicates that the observed effect is due to the binding of 
GpUpA to the anticodon of (Fllra)tRNA^®^. Further evidence to support this 
conclusion comes from the observation that formation of an anticodon-
anticodon complex (Eisinger, 1971; Grosjean et al., 1976) between 
(FUra)tRNAi*^ (anticodon FAC) and E, ooli tRNAp*" (anticodon QUA) produces 
a similar upfield shift of peak H (Fig. 24). On the basis of these 
results, the resonance at 3.90 ppm can be assigned to FUra-34 in the anti­
codon loop of (FUra)tRNAi*T. Such an assignment is consistent with 
evidence, discussed previously, which Indicates that the peaks in the 
central region of the NMR spectrum, including peak H, are derived from 
FUra residues in single-stranded regions of the tRNA. FUra H is acces­
sible to pH titration, having a pKa of 7.6, similar to that of free 5-
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fluorouridine (Fig. 8). Determination of the degree of solvent exposure 
by measurement of the solvent isotope shift (SIS) on transfer of the tRNA 
from H2O to (Hardin, 1984), indicates that FUra H has a SIS value 
close to that of free.5-fluorouridine and is, by this criterion, 
completely exposed. Furthermore, this FUra residue readily forms an 
adduct with bisulfite (Fig. 16), which preferentially reacts with pyrim-
idines in single-stranded regions of tRNA (Furuichi et al., 1970). 
Several studies, including psoralen photoaddition (Fig. 17) and 
ethidium bromide intercalation (W. C. Chu and J. Horowitz, Dept. of 
Biochemistry and Biophysics, Iowa State Univ., unpublished results) 
indicate that the resonances in the upfield portion (above 3.5 ppm) of the 
^^F spectrum of (FUra)tRNA2®^ are derived from FUra residues located in 
helical regions of the tRNA. It follows that when the environment of a 
FUra residue is changed from single-stranded to base-paired, an upfield 
shift occurs, as when GpUpA is bound to the anticodon. 
Binding of GpUpApA to (FUra)tRNA-[®^ also shifts the ^®F peak at 3.90 
ppm upfield (Fig. 21), which indicates that this tetranucleotide also 
binds to the anticodon region of the tRNA. Additional evidence to support 
this conclusion comes from the observation that GpUpApA binding affects 
the ^H NMR signal from m^A-36, 3'-adjacent to the anticodon in tRNAj®^. 
It was also shown that ribonuclease H cleaves the complex of 
dGpTpApA:(FUra)tRNAonly at position 34 in the anticodon (Fig. 28), and 
since dGpTpApA has similar effects on the ^^F NMR spectrum as GpUpApA, it 
is reasonable to conclude that the codon-containing oligoribonucleotides 
also bind only at the anticodon of (FUra)tRNA][®^. 
The tetranucleotide GpUpApA binds to the anticodon of (FUra)tRNAi[®^ 
much more tightly than the codon triplet GpUpA does. This increased bind­
ing affinity may be due to formation of a fourth base-pair, since the 3'-
terminal adenosine of GpUpApA is complementary to the FUra residue at 
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position 33, adjacent to the 5' end of the anticodon. However, an alter­
native explanation for the increased binding is that the 3'-terminal aden­
osine stabilizes the binding by stacking on the preceding pair (3'-
dangling end effect), rather than by forming a base-pair. 
In addition to the upfield shift of peak H, GpUpApA binding induces a 
downfield shift of a second resonance at 4.5 ppm (peak F) (Fig. 21). It 
is possible that this shift reflects base-pairing between FUra-33 and the 
3'-terminal adenosine of the tetranucleotide. If this is true, then peak 
F can be assigned to FUra-33 of (Fllra)tRNAy®^, and this would also 
indicate that in solution the anticodon loop can undergo a conformational 
change from the 3'-stacked conformation observed in the crystal structure 
(Fig. IB). 
Because GpUpApA binds to the anticodon with over twice the affinity 
of GpUpA, it is possible that the downfield shift of peak F is caused only 
by the tighter binding. However, formation of an anticodon-anticodon 
complex between (FUra)tRNA2®^ and E. ooli tRNA^^"^ shifts peak H upfield 
but does not affect peak F (Fig. 24). Association constants for formation 
of such complexes are several orders of magnitude greater than those for 
complementary oligonucleotide binding to the anticodon (Grosjean et al., 
1976). This shows that the downfield shift of peak F cannot be attributed 
solely to the affinity of GpUpApA binding. 
Studies of tetranucleotides containing the codon GpUpA and a 
3'-nucleotide of U, G, or C, to (FUra)tRNA][®^ (Figs. 22 and 23; C not 
shown) show that the effect on the ^®F resonance at 4.60 ppm is specific 
for GpUpApA, indicating that this shift is not due to a nonspecific inter­
action of a 3'-dangling nucleoside. On the basis of these results, a 
preliminary assignment of one of the resonances at ca. 4.60 ppm (peak F) 
to FUra-33 of (FUra)tRNA-[®^ can be made. 
Addition of 3'-dangling ends to the codon does increase the binding 
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affinity of all the resulting tetranucleotides as compared to GpUpA. This 
is especially evident in the case of GpUpApG, which binds with higher 
affinity than either GpUpApC or GpUpApU, and, with an association constant 
twice that of GpUpA, GpUpApG binds nearly as tightly as GpUpApA. These 
findings agree with previous studies that have shown that purines are more 
efficient than pyrimidines at stabilizing short RNA duplexes as 
3'-dangling ends (Westhof et al., 1983; Freier et al., 1983, 1985). 
Support for the assignments of peak H and peak F to the FUra residues 
in the anticodon of (FUra)tRNAj®^ comes from the observation that both of 
these peaks are specifically affected when the tRNA is hydrolyzed by SI 
nuclease under conditions which lead to cleavage in the anticodon loop (P. 
Gollnick and J. Horowitz, Dept. of Biochemistry and Biophysics, Iowa State 
Univ., unpublished observations). In spectra recorded with or without 
Mg**, both peaks show a loss of intensity as compared to untreated 
(FUra)tRNA2®^ presumably due to partial removal of FUra-33 and FUra-34 by 
the nuclease. Peak F is also shifted downfield ca. 0.3 ppm in the spec­
trum of nuclease SI cleaved tRNA recorded in 15 mM MgCl2, possibly 
reflecting an altered environment resulting from cleavage of the loop. 
Formation of a base-pair between FUra-33 and the tetranucleotide 
requires that the anticodon loop undergo a conformational change from the 
3'-stacked conformation observed in the crystal structure (Fig. IB), 
perhaps to a 5'-stacked conformation first proposed by Fuller and Hodgson 
(1967) (see Fig. 33). As discussed in the introduction, there is exper­
imental evidence for conformational flexibility in the anticodon loop. 
Several NMR studies have provided evidence for multiple conformations in 
this loop (Gorenstein and Goldfield, 1982; Salemink et al., 19G0). The 
temperature dependence of fluorescence from the wye base in the anticodon 
loop of yeast tRNA^he shows structural transitions characterized as an 
"all-or-none" effect, which have been suggested to reflect a transition 
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Figure 33. Possible model for the conformational change in the anticodon 
loop 
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from the 3'-stacked to the 5'-stacked anticodon (Urbake and Maass, 1978). 
Several oligonucleotide binding studies also suggest that the anticodon 
can exist stacked on the 5'-s1de of the loop (Uhlenbeck et al., 1970; 
Elslnger and Spahr, 1973; Yoon et al., 1975; Geerdes et al., 1980a). The 
most convincing of these studies used NMR to demonstrate that four to 
five base-pairs are formed between the codon-contalning pentanucleotlde 
UpUpCpApG and the anticodon loop of tRNA^he Geerdes et al., 1980a). 
The two resonances In the NMR spectrum of (FUra)tRNA][®^ that have 
been assigned to the anticodon loop, peaks F and H, are the most sensitive 
to changes in temperature, either in the presence (Fig. 15) or absence 
(Hardin, 1984) of magnesium. This behavior also suggests conformational 
flexibility in the anticodon loop. 
The exact nature of the interaction between the 3'-terminal adenosine 
of GpUpApA and FUra-33 is somewhat unclear. For one thing, the shift of 
peak F upon binding the tetranucleotide is downfield (Fig. 21), rather 
than upfield as seen with peak H upon codon binding (Figs. 18 and 21). The 
downfield shift of peak F may reflect a conformational change in the anti­
codon loop near FUra-33, whereas the upfield shift of peak H only reflects 
the change due to base-pairing with the oligonucleotide. It is also 
possible that the shift of peak F is due to a conformational change in 
other parts of the molecule. While this cannot be completely ruled out, 
it seems unlikely since binding of GpUpA or GpUpApX (X= U, G, or C) or 
formation of an anticodon-anticodon complex with tRNA^^^ does not affect 
peak F. 
Addition of UpApA, which is a constituent of GpUpApA, and is comple­
mentary to FUra-33 and the first two residues of the anticodon, does not 
perturb the ^®F spectrum of (FUra)tRNA^*1 (Fig. 20). This may be due to 
insufficient binding affinity, because of the lack of a G-C base pair, or 
UpApA may not bind due to the conformation of the anticodon loop, i.e., if 
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the loop exists in the 3' stack, position 33 is not available for binding 
(see Fig. 33). If UpApA doesn't bind to (FUra)tRNA-[®^ due to the confor­
mation of the loop, then this suggests that GpUpApA binding induces a 
conformational change which allows the 3'-terminal adenosine to base-pair 
with FUra-33. 
The conformation of the anticodon loop in the crystal structure of 
tRNA^he (Fig. IB) is stabilized by a magnesium hydrate ion; Mg** binds to 
a phosphate oxygen of residue 37, and the water molecules, coordinated to 
the Mg"*^ ion, form several hydrogen bonds to nearby bases of the loop 
(Holbrook et al., 1977; Quigley et al., 1978). It has been suggested that 
removal of the magnesium ion would result in a more flexible anticodon 
loop (Kim, 1980; Teeter et al., 1980). 
The results of codon binding to (FUra)tRNA-[®^ in the absence of mag­
nesium are consistent with an alternate anticodon loop structure. First, 
the binding constants obtained for either the tri- or tetranucleotide 
codon are much lower than those obtained in 15 mM Mg**. This may be a 
result of a change from the conformation of the anticodon loop seen in the 
crystal structures (Fig. IB), in which the anticodon is stacked perfectly 
to interact with a codon, to a structure less suited for codon binding. 
Also, GpUpA binding in the absence of Mg** shifts both peaks F and H, 
whereas in the presence of magnesium only peak His affected. If the 
structure of the anticodon loop in the presence of magnesium resembles 
that seen in the crystal (Fig. IB) binding of a codon trinucleotide might 
affect the environment of the base at position 34 while position 33 
remains unperturbed. This is because residue 33 is separated from the 
anticodon by a sharp bend in the polynucleotide backbone. Removal of 
magnesium may alter the conformation of the anticodon loop in such a way 
so that U-33 is no longer separated from the anticodon, and codon binding 
now perturbs the environment of this base. 
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GpUpApA binding also affects peak F differently in the absence of 
magnesium, causing an upfield shift rather than the downfield shift 
observed in 15 mM Mg**. Earlier it was suggested that the upfield shift 
of peak H upon codon binding reflects a change in the environment of 
FUra-34 from single-stranded to hydrogen-bonded, and that the downfield 
shift of peak F may be due to a more complicated change in the structure 
around FUra-33, possibly involving a conformational change from the 3' 
stack. The upfield shift of peak F upon addition of GpUpApA in the 
absence of Mg** clearly Indicates that a different type of interaction 
occurs between the tetranucleotide and the anticodon in the absence of 
Mg"*^ than in the presence of magnesium. The upfield shift of peak F may 
indicate that at low Mg** the anticodon loop structure is such that the 
3'-terminal adenosine of GpUpApA can base-pair directly with FUra-33 with­
out any conformational change. 
In the crystal structure of yeast tRNA^he, the conformation of the 
anticodon arm is affected by the presence of a spermine molecule bound to 
the anticodon stem (Fig. IB). The positively charged polycation draws the 
anionic phosphate groups on the opposite sides of the major groove 
together, and produces a bend in the double helix. Together with the 
bound magnesium, spermine has the effect of substantially immobilizing the 
anticodon (Teeter et al., 1980). Fluorescence studies of spermine binding 
to a tRNA^he derivative carrying ethidium at position 37 in the anticodon 
have shown that spermine stabilizes one particular conformation of the 
anticodon loop (Nilsson et al., 1983). These studies also show that the 
polyamine stabilizes the same structure as Mg** does, but the mechanism of 
action is different. 
Addition of GpUpApA to FUra-substituted tRNAj®^ in the presence of 
spermine results in only the upfield shift of peak H, assigned to FUra-34 
(Fig. 29). Peak F, at 4.60 ppm, was not affected by GpUpApA in the 
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presence of spermine, as it was In the absence of the polyamlne (compare 
Fig. 29 to Fig. 21). If, as has been suggested, the downfield shift of 
peak F reflects pairing of FUra-33 with GpUpApA, then the lack of any 
effect in the presence of spermine suggests that spermine stabilizes a 
conformation of the anticodon in which FUra-33 is unable to interact with 
an oligonucleotide bound to the anticodon, possibly the 3'-stacked confor­
mation seen in crystals grown in the presence of spermine (Fig. IB). 
Binding of the trinucleotide codon ApUpG to (FUra)tRNAU}®* also 
induces an upfield shift of one resonance, peak I, in the central (4.0-5.5 
ppm) region of the ^®F NMR spectrum of this tRNA (Fig. 30). Because the 
shift is codon-specific, and the calculated binding constant agrees well 
with that in the literature, a preliminary assignment of peak I to Fura-36 
at the 3' position of the anticodon of (FUra)tRNA^®^ can be made. 
Interestingly, no changes in the ^®F NMR spectrum of FUra-substituted 
E, aoli initiator tRNA^^t are observed upon addition of the codon ApUpG 
(Fig. 31) or ApUpGpA (data not shown). This is surprising in view of an 
earlier report which showed that the affinity of E, ooli tRNAf^t for ApUpG 
is three times greater than that of tRNA^J®^ (Hogenauer et al., 1972). The 
anticodon loop of the (FUra)tRNAf®^ used in these experiment was intact, 
as judged by polyacrylamide gel electrophoresis under denaturing condi­
tions (7 M urea) (Data not shown). This would indicate two possible 
explanations for the lack of any effect of ApUpG on the spectrum of 
(FUra)tRNA^®^: a low binding constant for codon; or, in contrast to the 
results with tRNA^®^ and tRNA^^*, binding of the oligonucleotide to 
tRNAf®^ does not affect the magnetic environment of FUra-36 in the anti­
codon. Subtle conformational differences between the anticodon loop of 
initiator tRNAs and elongator tRNAs have been detected by X-ray diffrac­
tion analysis of tRNA crystals (Woo et al., 1980) and by enzymatic 
(nuclease SI) analysis (Wrede et al., 1979). It is also possible that 
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incorporation of 5-fluorouracil has affected the structure of the anti-
codon loop resulting in a conformation unfavorable for codon binding. 
Other studies have indicated that (FUra)tRNA^^ interacts with initiation 
factor in an unusual manner (J. Horowitz, Dept. of Biochemisty and 
Biophysics, Iowa State Univ., and I. Schwarz, New York Med. Col., 
unpublished results). 
chemical shifts are extremely sensitive to the environment of the 
fluorine atom. Yet oligonucleotide codon binding to (FUra)tRNA][®^ and 
(FUraltRNA^Gt results in the shift of only one or two peaks in the ^®F NMR 
spectra of these tRNAs, presumably the FUra residues located in the anti-
codon. No other significant changes in the spectra are observed. There 
is no evidence for trinucleotide codon-induced aggregation of (FUra)tRNA 
such as that observed with several other tRNAs (Porschke and Labuda, 1982; 
Geerdes et al., 1980b; Clore et al., 1984); the resonances in the ^^F NMR 
spectra are not broadened by codon binding (Figs. 18, 21, and 30), as they 
are upon formation of an anticodon-anticodon dimer between (FUra)tRNA][^^ 
and tRNA^ry (Fig. 20). 
There are no indications of more far reaching conformational changes 
in the tRNA such as a disruption of the interactions between the D and T 
loops. This conclusion is supported by the lack of any effect of CpGpApA 
addition on the ^®F NMR spectrum of (FUra)tRNA2®^, either in the absence 
or presence of the codon GpUpA (Fig. 32), and similar results were also 
obtained using a pentanucleotide codon GpUpApApA (results not shown). A 
number of experiments, discussed previously, have suggested that the two 
farthest downfield peaks in the ^^F spectrum of (FUra)tRNA][®^ represent 
FUra 54 and 55 (Hardin, 1984). Codon binding, either oligonucleotide 
codons, or the complementary anticodon of E. ooli tRNA^^**, has no effect 
on peak A or B in the ^^F NMR spectrum of (FUra)tRNAi*1 (Figs. 18, 21 and 
24). Binding of the tetranucleotlde to the FpFpCpG in the T loop should 
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certainly have resulted in the shift of one or more signals, as occurs 
when oligonucleotide codons bind to the anticodon of several FUra-
substituted tRNAs. The absence of such shifts indicates that the FpFpCpG 
sequence is not available for oligonucleotide binding, even when codon is 
bound to the anticodon. This is consistent with the results of proton NMR 
studies (Geerdes et al., 1978, 1980a; Davanloo et al., 1979). The possi­
bility of small conformational changes, which do not change the magnetic 
environment of any of the incorporated fluorines in the tRNA cannot be 
ruled out. 
A high concentration of CpGpApA does, however, cause the shift qf 
several resonances in the 2.5-3.5 ppm region of the ^^F spectrum of 
(FUraitRNAi^l when the anticodon of the tRNA is bound in a tight complex 
to the complementary anticodon of E. ooli tRNAp"" (data not shown). The 
resonances affected, however, are not those corresponding to the FUra 
residues at positions 54 and 55 in the T loop (peaks A and B). Further 
investigation will be necessary to determine the nature of the structural 
change and whether this represents a specific effect of OpGpApA. 
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